FR13C0051I1 - Administration d'antipsychotiques par inhalation - Google Patents

Administration d'antipsychotiques par inhalation

Info

Publication number: FR13C0051I1
Authority: FR; France
Prior art keywords: antipsychotic; inhalation; composition; mammal; present
Prior art date: 2001-05-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR13C0051C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alexza Pharmaceuticals Inc

Original Assignee

Alexza Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-24

Filing date

2013-08-19

Publication date

2013-09-27

2013-08-19 Application filed by Alexza Pharmaceuticals Inc filed Critical Alexza Pharmaceuticals Inc

2013-09-27 Publication of FR13C0051I1 publication Critical patent/FR13C0051I1/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24V—COLLECTION, PRODUCTION OR USE OF HEAT NOT OTHERWISE PROVIDED FOR
- F24V30/00—Apparatus or devices using heat produced by exothermal chemical reactions other than combustion
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
- A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Dispersion Chemistry (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Otolaryngology (AREA)
Mechanical Engineering (AREA)
Combustion & Propulsion (AREA)
Thermal Sciences (AREA)
Physics & Mathematics (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gynecology & Obstetrics (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)

FR13C0051C 2001-05-24 2013-08-19 Administration d'antipsychotiques par inhalation Active FR13C0051I1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29420301P	2001-05-24	2001-05-24
US31747901P	2001-09-05	2001-09-05
PCT/US2002/016118 WO2002094236A1 (en)	2001-05-24	2002-05-20	Delivery of antipsychotics through an inhalation route

Publications (1)

Publication Number	Publication Date
FR13C0051I1 true FR13C0051I1 (fr)	2013-09-27

Family

ID=30772632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR13C0051C Active FR13C0051I1 (fr)	2001-05-24	2013-08-19	Administration d'antipsychotiques par inhalation

Country Status (16)

Country	Link
US (75)	US6737042B2 (ja)
EP (14)	EP1392262A1 (ja)
JP (7)	JP2005503425A (ja)
AT (11)	ATE462420T1 (ja)
AU (3)	AU2002314784A1 (ja)
BE (1)	BE2013C054I2 (ja)
CA (7)	CA2446904A1 (ja)
DE (4)	DE60235851D1 (ja)
DK (1)	DK1389098T3 (ja)
ES (5)	ES2341594T3 (ja)
FR (1)	FR13C0051I1 (ja)
MX (2)	MXPA03010703A (ja)
NZ (6)	NZ529422A (ja)
PL (3)	PL363996A1 (ja)
PT (2)	PT1389098E (ja)
WO (1)	WO2002094236A1 (ja)

Families Citing this family (391)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030203036A1 (en) *	2000-03-17	2003-10-30	Gordon Marc S.	Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US7632517B2 (en) *	1997-10-01	2009-12-15	Novadel Pharma Inc.	Buccal, polar and non-polar spray containing zolpidem
US7087215B2 (en) *	1998-12-21	2006-08-08	Generex Pharmaceuticals Incorporated	Methods of administering and enhancing absorption of pharmaceutical agents
US7258850B2 (en) *	1999-05-04	2007-08-21	Aradigm Corporation	Methods and compositions for treating erectile dysfunction
PT1218049E (pt) *	1999-07-12	2007-01-31	Capnia Inc	Aparelho para o alívio de dores de cabeça, rinite e outros padecimentos comuns
US20060172017A1 (en)	1999-11-08	2006-08-03	Capnia, Incorporated	Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
CA2389294A1 (en) *	1999-11-08	2001-05-25	Capnia, Incorporated	Method and apparatus for relieving ailments using gases to increase the effectiveness of drugs
US20070039615A1 (en) *	1999-11-08	2007-02-22	Capnia, Incorporated	Methods and apparatus for treating rhinitis
EP1233651A1 (en) *	2000-04-07	2002-08-21	Ibiden Co., Ltd.	Ceramic heater
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
WO2002009669A2 (en) *	2000-08-01	2002-02-07	Inhale Therapeutic Systems, Inc.	Apparatus and process to produce particles having a narrow size distribution and particles made thereby
US20020169507A1 (en) *	2000-12-14	2002-11-14	David Malone	Interbody spine fusion cage
SE0101204D0 (sv) *	2001-04-04	2001-04-04	Siemens Elema Ab	Heating device for respiration gas
EP1392262A1 (en)	2001-05-24	2004-03-03	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
US6759029B2 (en)	2001-05-24	2004-07-06	Alexza Molecular Delivery Corporation	Delivery of rizatriptan and zolmitriptan through an inhalation route
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7498019B2 (en)	2001-05-24	2009-03-03	Alexza Pharmaceuticals, Inc.	Delivery of compounds for the treatment of headache through an inhalation route
ES2316571T3 (es) *	2001-05-24	2009-04-16	Alexza Pharmaceuticals, Inc.	Administracion de alprazolam, estazolam, midazolam o triazolam a traves de una via inhalatoria.
US7090830B2 (en) *	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US7645442B2 (en)	2001-05-24	2010-01-12	Alexza Pharmaceuticals, Inc.	Rapid-heating drug delivery article and method of use
US20030131843A1 (en) *	2001-11-21	2003-07-17	Lu Amy T.	Open-celled substrates for drug delivery
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
WO2003041693A1 (en)	2001-11-09	2003-05-22	Alexza Molecular Delivery Corporation	Delivery of diazepam through an inhalation route
EP1446102A1 (en) *	2001-11-21	2004-08-18	Alexza Molecular Delivery Corporation	Delivery of caffeine through an inhalation route
US7523065B2 (en) *	2001-12-12	2009-04-21	Asset Trust, Inc.	Risk transfer supply chain system
GB2384184B (en) *	2002-01-10	2005-01-12	Aea Technology Plc	Cannabis aerosol
US7582284B2 (en) *	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
GB0216562D0 (en) *	2002-04-25	2002-08-28	Bradford Particle Design Ltd	Particulate materials
US9339459B2 (en)	2003-04-24	2016-05-17	Nektar Therapeutics	Particulate materials
EP1503744A1 (en) *	2002-05-13	2005-02-09	Alexza Molecular Delivery Corporation	Delivery of drug amines through an inhalation route
US20060193788A1 (en) *	2002-11-26	2006-08-31	Hale Ron L	Acute treatment of headache with phenothiazine antipsychotics
AU2003247515A1 (en) *	2002-06-10	2003-12-22	Wyeth	Novel formate salt of o-desmethyl-venlafaxine
DE10234165B4 (de) *	2002-07-26	2008-01-03	Advanced Micro Devices, Inc., Sunnyvale	Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
US20040076671A1 (en) *	2002-10-21	2004-04-22	Aletha Tippett	Methods and compositions for topical wound treatment
US7644715B2 (en) *	2002-10-31	2010-01-12	Cooltouch, Incorporated	Restless leg syndrome treatment
CA2507159A1 (en) *	2002-11-26	2004-06-10	Alexza Molecular Delivery Corporation	Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
US7550133B2 (en) *	2002-11-26	2009-06-23	Alexza Pharmaceuticals, Inc.	Respiratory drug condensation aerosols and methods of making and using them
CA2507158A1 (en) *	2002-11-26	2004-06-10	Alexza Molecular Delivery Corporation	Treatment of headache with antipsychotics delivered by inhalation
US20040105818A1 (en)	2002-11-26	2004-06-03	Alexza Molecular Delivery Corporation	Diuretic aerosols and methods of making and using them
US7913688B2 (en)	2002-11-27	2011-03-29	Alexza Pharmaceuticals, Inc.	Inhalation device for producing a drug aerosol
JP2006516963A (ja) *	2003-02-04	2006-07-13	クリサリステクノロジーズインコーポレイテッド	エアロゾル製剤及びブスピロン、ブプレノルフィン、トリアゾラム、シクロベンザプリン及びゾルピデムのエアロゾル送出
KR20070011344A (ko) *	2003-02-28	2007-01-24	데렉스 쎄라퓨틱스 인코포레이티드	오피오이드 전달 시스템
DE602004020597D1 (de) *	2003-02-28	2009-05-28	Ym Biosciences Inc	Opioidabgabesystem
US7648981B2 (en)	2003-02-28	2010-01-19	Ym Biosciences Inc.	Opioid delivery system
US7648982B2 (en)	2003-02-28	2010-01-19	Ym Biosciences Inc.	Opioid delivery system
US20040204439A1 (en) *	2003-04-14	2004-10-14	Staniforth John Nicholas	Composition, device, and method for treating sexual dysfunction via inhalation
WO2004089374A1 (en) *	2003-04-14	2004-10-21	Vectura Ltd	Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
JP2007516149A (ja) *	2003-05-21	2007-06-21	アレックザファーマシューティカルズ，インコーポレイテッド	基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
GB0314149D0 (en) *	2003-06-18	2003-07-23	Generics Uk Ltd	Novel amorphous forms
US20040265238A1 (en) *	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
CN2718561Y (zh) *	2003-07-11	2005-08-17	艾康生物技术(杭州)有限公司	用于取样签的保护套
US20050042177A1 (en) *	2003-07-23	2005-02-24	Elan Pharma International Ltd.	Novel compositions of sildenafil free base
NZ527142A (en) *	2003-07-23	2006-03-31	Douglas Pharmaceuticals Ltd	A stable suspension formulation
US20050037506A1 (en) *	2003-08-04	2005-02-17	Alexza Molecular Delivery Corporation	Methods of determining film thicknesses for an aerosol delivery article
ATE470468T1 (de) *	2003-08-04	2010-06-15	Alexza Pharmaceuticals Inc	Substrate für eine medikamentenverabreichungsvorrichtung und verfahren zur bereitung
EP1663159A4 (en) *	2003-09-10	2010-06-09	Map Pharmaceuticals Inc	AEROSOL FORMULATIONS FOR THE DELIVERY OF DIHYDROERGOTAMINE TO THE SYSTEMIC CIRCULATION BY PULMONARY INHALATION
WO2005025550A1 (en) *	2003-09-15	2005-03-24	Vectura Limited	Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
CN1305266C (zh) *	2003-12-19	2007-03-14	深圳国人通信有限公司	基于嵌入式系统的无线局域网接入点设备
US20050171088A1 (en) *	2004-01-30	2005-08-04	Astrazeneca Ab	Treatment of psychoses with dibenzothiazepine antipsychotic
US20050256553A1 (en) *	2004-02-09	2005-11-17	John Strisower	Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation
CN100452898C (zh) *	2004-03-04	2009-01-14	Ut斯达康通讯有限公司	无线基站中的负荷分担方法与系统
US7422224B2 (en) *	2004-04-13	2008-09-09	Kimir Seatpost	Adjustable bicycle seat post assembly
US7402777B2 (en)	2004-05-20	2008-07-22	Alexza Pharmaceuticals, Inc.	Stable initiator compositions and igniters
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1781360A1 (en)	2004-08-12	2007-05-09	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
US20100006092A1 (en) *	2004-08-12	2010-01-14	Alexza Pharmaceuticals, Inc.	Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
US20060039869A1 (en) *	2004-08-17	2006-02-23	Daniel Wermeling	Intranasal delivery of antipsychotic drugs
EP1809240A4 (en) *	2004-10-12	2010-06-16	Alexza Pharmaceuticals Inc	ADMINISTRATION OF A DRUG-FREE DRUG WITHOUT DANGER TO THE CARDIOVASCULAR SYSTEM
GB0425758D0 (en)	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
US8691995B2 (en) *	2004-12-16	2014-04-08	Cipla Limited	Process
US7827983B2 (en) *	2004-12-20	2010-11-09	Hewlett-Packard Development Company, L.P.	Method for making a pharmaceutically active ingredient abuse-prevention device
US20060130829A1 (en) *	2004-12-20	2006-06-22	Sexton Douglas A	Inhalation device
CA2605473C (en) *	2005-04-21	2013-10-29	Medichem, S.A.	Process for preparing quetiapine and quetiapine fumarate
US8062901B2 (en) *	2005-04-30	2011-11-22	Alere Switzerland Gmbh	Devices and methods for sample collection and analysis
US20090117660A1 (en) *	2005-04-30	2009-05-07	Oakville Hong Kong Co., Limited	Devices and methods for sample collection and analysis
CA2578626C (en)	2005-06-27	2011-07-19	Biovail Laboratories International S.R.L.	Modified-release formulations of a bupropion salt
BRPI0615972A2 (pt)	2005-07-29	2011-05-31	Concert Pharmaceuticals Inc	composto isolado, mistura, composição, item de manufatura, uso de um composto, método para determinar a concentração do composto em uma amostra biológica, kit de diagnóstico e método para avaliar a estabilidade metabólica de um composto
JP2009507925A (ja) *	2005-09-13	2009-02-26	エランファーマインターナショナルリミテッド	ナノ粒子タダラフィル製剤
US20070092401A1 (en) *	2005-10-26	2007-04-26	Feier Liao	Devices and methods for sample collection and analysis
JP5478070B2 (ja) *	2005-12-01	2014-04-23	ヴェイポアエルエルシー	改良された毛管力蒸発装置
US8252329B2 (en) *	2007-01-05	2012-08-28	Acelrx Pharmaceuticals, Inc.	Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en)	2006-01-06	2014-06-17	Acelrx Pharmaceuticals, Inc.	Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) *	2006-01-06	2013-01-22	Acelrx Pharmaceuticals, Inc.	Drug dispensing device with flexible push rod
US9289583B2 (en)	2006-01-06	2016-03-22	Acelrx Pharmaceuticals, Inc.	Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en)	2006-01-06	2012-06-19	Acelrx Pharmaceuticals, Inc.	Small-volume oral transmucosal dosage forms
US8865743B2 (en)	2006-01-06	2014-10-21	Acelrx Pharmaceuticals, Inc.	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en)	2007-01-05	2015-06-30	Aceirx Pharmaceuticals, Inc.	Storage and dispensing devices for administration of oral transmucosal dosage forms
US8535714B2 (en)	2006-01-06	2013-09-17	Acelrx Pharmaceuticals, Inc.	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en)	2006-01-06	2012-08-28	Acelrx Pharmaceuticals, Inc.	Bioadhesive drug formulations for oral transmucosal delivery
WO2007083073A1 (en)	2006-01-19	2007-07-26	Optinose As	Nasal administration
US20070183351A1 (en) *	2006-02-03	2007-08-09	Motorola, Inc.	Method and apparatus for providing service in a multi-ran communication network
WO2007123945A2 (en) *	2006-04-21	2007-11-01	Aradigm Corporation	Mechanical single dose intrapulmonary drug delivery devices
US7909033B2 (en)	2006-05-03	2011-03-22	Comedica Incorporated	Breathing treatment apparatus
US8536445B2 (en) *	2006-06-02	2013-09-17	Emcore Solar Power, Inc.	Inverted metamorphic multijunction solar cells
US20070299687A1 (en) *	2006-06-23	2007-12-27	Pamela Palmer	Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US8051854B2 (en) *	2006-09-15	2011-11-08	Comedica Incorporated	Continuous high-frequency oscillation breathing treatment apparatus
US20090270438A1 (en) *	2006-10-18	2009-10-29	Clive Booles	Novel compositions and formulations
GB0620661D0 (en) *	2006-10-18	2006-11-29	Pharmasol Ltd	Novel compounds
US20080102097A1 (en) *	2006-10-31	2008-05-01	Zanella John M	Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
US8279765B2 (en) *	2006-11-13	2012-10-02	Motorola Solutions, Inc.	Method and apparatus for interworking in an inter-technology network
US20080154374A1 (en) *	2006-12-20	2008-06-26	Robert David Labrom	Joint implant and a surgical method associated therewith
US20080299048A1 (en) *	2006-12-22	2008-12-04	Alexza Pharmaceuticals, Inc.	Mixed drug aerosol compositions
US20080275030A1 (en) *	2007-01-19	2008-11-06	Sveinbjorn Gizurarson	Methods and Compositions for the Delivery of a Therapeutic Agent
DK2425820T3 (en)	2007-02-11	2015-07-13	Map Pharmaceuticals Inc	A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
EP2121088B1 (en)	2007-03-09	2016-07-13	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
CA2681628C (en)	2007-03-16	2016-10-18	Concert Pharmaceuticals, Inc.	Inhibitors of cholesterol ester transfer protein
WO2008116165A2 (en) *	2007-03-21	2008-09-25	Next Safety, Inc.	Methods and systems of delivering medication via inhalation
CA2701638A1 (en) *	2007-04-02	2008-10-09	Concert Pharmaceuticals Inc.	Pharmaceutical calcimimetics
GB2448183A (en) *	2007-04-05	2008-10-08	Optinose As	Nasal powder delivery device
EP2134323A4 (en) *	2007-04-06	2012-03-07	Rhode Island Education	REDUCTION OF PROTEINS ASSOCIATED WITH ALZHEIMER DISEASE BY INTERRUPTING GENE TRANSCRIPTIONS WITH A SMALL MOLECULE
WO2008128166A1 (en) *	2007-04-13	2008-10-23	Concert Pharmaceuticals Inc.	Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
US7528131B2 (en) *	2007-04-19	2009-05-05	Concert Pharmaceuticals Inc.	Substituted morpholinyl compounds
US20090042842A1 (en)	2007-04-25	2009-02-12	Concert Pharmaceuticals, Inc.	Analogues of cilostazol
MX341177B (es)	2007-05-01	2016-08-10	Concert Pharmaceuticals Inc	Compuestos de morfina.
CA2685924A1 (en)	2007-05-01	2008-11-13	Concert Pharmaceuticals Inc.	Naphthyl(ethyl)acetamides
EP2522667B1 (en) *	2007-05-01	2014-08-20	Concert Pharmaceuticals Inc.	Morphinan compounds
PT2357183E (pt)	2007-05-01	2015-09-28	Concert Pharmaceuticals Inc	Compostos de morfinano
WO2008141021A1 (en) *	2007-05-08	2008-11-20	Concert Pharmaceuticals, Inc.	Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
US9050434B2 (en) *	2007-05-18	2015-06-09	Comedica Incorporated	Lung therapy device
PL2003120T3 (pl)	2007-06-12	2010-04-30	Concert Pharmaceuticals Inc	Pochodne azapeptydu jako inhibitory proteazy HIV
WO2009009531A2 (en) *	2007-07-09	2009-01-15	Concert Pharmaceuticals Inc.	Pyrimidinecarboxamide derivatives for the treatment of hiv infections
US8442390B2 (en) *	2007-08-29	2013-05-14	Philip Morris Usa Inc.	Pulsed aerosol generation
JP5647519B2 (ja)	2007-09-13	2014-12-24	コンサートファーマシューティカルズインコーポレイテッド	重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成
US8470360B2 (en)	2008-04-18	2013-06-25	Warsaw Orthopedic, Inc.	Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
US20090104964A1 (en) *	2007-10-17	2009-04-23	Igt	Gaming system, gaming device and gaming method providing player physical activation of the symbol generator
EP2212298B1 (en) *	2007-10-18	2013-03-27	Concert Pharmaceuticals Inc.	Deuterated etravirine
GB0721394D0 (en) *	2007-10-31	2007-12-12	Vectura Group Plc	Compositions for trating parkinson's disease
US20090162421A1 (en) *	2007-12-21	2009-06-25	Paz Arzneimittel-Entwicklungsgesellschaft Mbh	Drugs as well as their production and use in the treatment of pain-associated neuropathies
US9138430B2 (en) *	2007-12-27	2015-09-22	Mylan Specialty L.P.	Formulation and method for the release of paroxetine in the large intestine
EP2262502A4 (en) *	2008-02-05	2011-12-28	Clera Inc	Compositions and methods for alleviating depression or improving cognition
AU2009212166A1 (en)	2008-02-07	2009-08-13	University Of Washington	Circumferential aerosol device
MX2010009300A (es)	2008-02-29	2010-11-05	Concert Pharmaceuticals Inc	Derivados de xantina substituidos.
KR101672511B1 (ko)	2008-03-06	2016-11-03	아나코르 파마슈티칼스 인코포레이티드	소염제로써 붕소가 함유된 소분자
US8201752B2 (en) *	2008-03-10	2012-06-19	Vapore, Inc.	Low energy vaporization of liquids: apparatus and methods
US9132119B2 (en)	2008-04-18	2015-09-15	Medtronic, Inc.	Clonidine formulation in a polyorthoester carrier
US20090263451A1 (en) *	2008-04-18	2009-10-22	Warsaw Orthopedic, Inc.	Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
US8946277B2 (en) *	2008-04-18	2015-02-03	Warsaw Orthopedic, Inc.	Clonidine formulations in a biodegradable polymer carrier
US20090264489A1 (en) *	2008-04-18	2009-10-22	Warsaw Orthopedic, Inc.	Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
US9610243B2 (en)	2008-04-18	2017-04-04	Warsaw Orthopedic, Inc.	Clonidine compounds in a biodegradable polymer
US8629172B2 (en) *	2008-04-18	2014-01-14	Warsaw Orthopedic, Inc.	Methods and compositions for treating post-operative pain comprising clonidine
US20090263489A1 (en) *	2008-04-18	2009-10-22	Warsaw Orthopedic, Inc.	Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
US8420114B2 (en) *	2008-04-18	2013-04-16	Warsaw Orthopedic, Inc.	Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US9132085B2 (en)	2008-04-18	2015-09-15	Warsaw Orthopedic, Inc.	Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US8889173B2 (en) *	2008-04-18	2014-11-18	Warsaw Orthopedic, Inc.	Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US20090264477A1 (en) *	2008-04-18	2009-10-22	Warsaw Orthopedic, Inc., An Indiana Corporation	Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US9072727B2 (en)	2008-04-18	2015-07-07	Warsaw Orthopedic, Inc.	Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US8722079B2 (en) *	2008-04-18	2014-05-13	Warsaw Orthopedic, Inc.	Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
USRE48948E1 (en)	2008-04-18	2022-03-01	Warsaw Orthopedic, Inc.	Clonidine compounds in a biodegradable polymer
US8956641B2 (en) *	2008-04-18	2015-02-17	Warsaw Orthopedic, Inc.	Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8883768B2 (en) *	2008-04-18	2014-11-11	Warsaw Orthopedic, Inc.	Fluocinolone implants to protect against undesirable bone and cartilage destruction
US8557273B2 (en)	2008-04-18	2013-10-15	Medtronic, Inc.	Medical devices and methods including polymers having biologically active agents therein
US20100017001A1 (en) *	2008-04-24	2010-01-21	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Computational system and method for memory modification
US9560967B2 (en)	2008-04-24	2017-02-07	The Invention Science Fund I Llc	Systems and apparatus for measuring a bioactive agent effect
US9662391B2 (en)	2008-04-24	2017-05-30	The Invention Science Fund I Llc	Side effect ameliorating combination therapeutic products and systems
US9649469B2 (en)	2008-04-24	2017-05-16	The Invention Science Fund I Llc	Methods and systems for presenting a combination treatment
US9282927B2 (en)	2008-04-24	2016-03-15	Invention Science Fund I, Llc	Methods and systems for modifying bioactive agent use
US9449150B2 (en)	2008-04-24	2016-09-20	The Invention Science Fund I, Llc	Combination treatment selection methods and systems
NZ589742A (en) *	2008-05-27	2012-06-29	Univ Melbourne	Methods of treating mammals with eustachian tube dysfunctions with betahistine
US7845277B2 (en) *	2008-05-28	2010-12-07	Autoliv Asp, Inc.	Header assembly
US20110160253A1 (en) *	2008-05-28	2011-06-30	Harbeson Scott L	Deuterated tizanidine
US20100221221A1 (en) *	2008-08-12	2010-09-02	Concert Pharmaceuticals Inc.	N-phenyl-2-pyrimidineamine derivatives
EP2334686B1 (en)	2008-08-28	2019-02-27	President and Fellows of Harvard College	Cortistatin analogues and syntheses therof
US7834295B2 (en)	2008-09-16	2010-11-16	Alexza Pharmaceuticals, Inc.	Printable igniters
US20100065052A1 (en) *	2008-09-16	2010-03-18	Alexza Pharmaceuticals, Inc.	Heating Units
WO2010033801A1 (en)	2008-09-19	2010-03-25	Concert Pharmaceuticals Inc.	Morphinan compounds
US20100098746A1 (en) *	2008-10-20	2010-04-22	Warsaw Orthopedic, Inc.	Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
EP2364151A1 (en)	2008-10-30	2011-09-14	Concert Pharmaceuticals Inc.	Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
WO2010062692A1 (en)	2008-10-30	2010-06-03	Concert Pharmaceuticals Inc.	Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
US8198268B2 (en) *	2008-10-31	2012-06-12	Janssen Biotech, Inc.	Tianeptine sulfate salt forms and methods of making and using the same
KR20110093832A (ko)	2008-11-04	2011-08-18	앵커 테라퓨틱스, 인코포레이티드	Ｃｘｃｒ4 수용체 화합물
US8945592B2 (en)	2008-11-21	2015-02-03	Acelrx Pharmaceuticals, Inc.	Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US8822546B2 (en) *	2008-12-01	2014-09-02	Medtronic, Inc.	Flowable pharmaceutical depot
US20100196286A1 (en) *	2008-12-01	2010-08-05	Armer Thomas A	Inhalation delivery methods and devices
US20110313004A1 (en)	2008-12-04	2011-12-22	Concert Pharmaceuticals, Inc.	Deuterated pyridinones
USD632782S1 (en) *	2008-12-08	2011-02-15	Margarita Aguilo-Pinedo	Liquid medication container and oral dispenser
WO2010074753A1 (en) *	2008-12-23	2010-07-01	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
US20100163027A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US20100163036A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US20100169259A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US8712794B2 (en) *	2008-12-30	2014-04-29	The Invention Science Fund I, Llc	Methods and systems for presenting an inhalation experience
US20100168529A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US20100163025A1 (en) *	2008-12-30	2010-07-01	Searete Llc	Methods and systems for presenting an inhalation experience
US8706518B2 (en) *	2008-12-30	2014-04-22	The Invention Science Fund I, Llc	Methods and systems for presenting an inhalation experience
US20100166613A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US8725529B2 (en)	2008-12-30	2014-05-13	The Invention Science Fund I, Llc	Methods and systems for presenting an inhalation experience
US8694330B2 (en) *	2008-12-30	2014-04-08	The Invention Science Fund I, Llc	Methods and systems for presenting an inhalation experience
US20100168525A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US20100169260A1 (en) *	2008-12-30	2010-07-01	Searete Llc	Methods and systems for presenting an inhalation experience
US20100163034A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US8738395B2 (en) *	2008-12-30	2014-05-27	The Invention Science Fund I, Llc	Methods and systems for presenting an inhalation experience
US20100168602A1 (en) *	2008-12-30	2010-07-01	Searete Llc	Methods and systems for presenting an inhalation experience
US20100163033A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US20100163024A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation	Methods and systems for presenting an inhalation experience
US20100163038A1 (en) *	2008-12-30	2010-07-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for presenting an inhalation experience
US20110053961A1 (en)	2009-02-27	2011-03-03	Concert Pharmaceuticals, Inc.	Substituted xanthine derivatives
US20100228097A1 (en) *	2009-03-04	2010-09-09	Warsaw Orthopedic, Inc.	Methods and compositions to diagnose pain
EP2229980B1 (en) *	2009-03-16	2015-08-12	Nuvolase, Inc.	Treatment of microbiological pathogens in a toe nail with antimicrobial light
BRPI1009199A2 (pt)	2009-03-17	2016-03-08	Concert Pharmaceuticals Inc	compostos de pirazinoisoquinolina
ES2750359T3 (es) *	2009-03-18	2020-03-25	Incarda Therapeutics Inc	Dosis unitarias, aerosoles, kits y procedimientos para tratar afecciones cardíacas mediante administración pulmonar
US8548623B2 (en)	2009-03-18	2013-10-01	Acelrx Pharmaceuticals, Inc.	Storage and dispensing devices for administration of oral transmucosal dosage forms
US20100239632A1 (en) *	2009-03-23	2010-09-23	Warsaw Orthopedic, Inc.	Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US20100300433A1 (en) *	2009-05-28	2010-12-02	Alexza Pharmaceuticals, Inc.	Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
WO2010138889A1 (en)	2009-05-28	2010-12-02	Concert Pharmaceuticals, Inc.	Peptides for the treatment of hcv infections
SI2443089T1 (sl)	2009-06-18	2014-07-31	Concert Pharmaceuticals, Inc.	Devterirani derivati izoindolin-1,3-diona kot inhibitorji pde4 in tnf-alfa
EP2454259A1 (en)	2009-06-23	2012-05-23	Concert Pharmaceuticals Inc.	Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
US20110171141A1 (en) *	2009-06-26	2011-07-14	Kellerman Donald J	Administration of dihydroergotamine mesylate particles using a metered dose inhaler
US8617583B2 (en) *	2009-07-17	2013-12-31	Warsaw Orthopedic, Inc.	Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
US20110015154A1 (en) *	2009-07-20	2011-01-20	Kellermann Gottfried H	Supporting acetylcholine function
US8814922B2 (en) *	2009-07-22	2014-08-26	New Star Lasers, Inc.	Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure
US8231891B2 (en) *	2009-07-31	2012-07-31	Warsaw Orthopedic, Inc.	Implantable drug depot for weight control
US10758582B2 (en) *	2009-08-17	2020-09-01	Xten Capital Group, Inc.	Vaporized medicants and methods of use
EA023922B1 (ru) *	2009-09-09	2016-07-29	Сенса Буэс Аб	Обнаружение лекарственного средства в выдыхаемом воздухе
IN2012DN02648A (ja)	2009-10-13	2015-09-11	Philip Morris Products Sa
WO2011047315A1 (en)	2009-10-15	2011-04-21	Concert Pharmaceuticals, Inc.	Subsitituted benzimidazoles
US20110097375A1 (en)	2009-10-26	2011-04-28	Warsaw Orthopedic, Inc.	Formulation for preventing or reducing bleeding at a surgical site
US20110098265A1 (en) *	2009-10-28	2011-04-28	Neuroscience, Inc.	Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
US20110100360A1 (en) *	2009-11-02	2011-05-05	Joseph Dee Faram	Composite lung therapy device and method
US9151425B2 (en) *	2009-11-02	2015-10-06	Comedica Incorporated	Multiple conduit connector apparatus and method
WO2011094450A1 (en)	2010-01-27	2011-08-04	Anacor Pharmaceuticals, Inc	Boron-containing small molecules
WO2011103457A1 (en)	2010-02-18	2011-08-25	Concert Pharmaceuticals Inc.	Pyrimidine derivatives
US9155795B2 (en)	2010-02-26	2015-10-13	Anchor Therapeutics, Inc.	CXCR4 receptor compounds
US8575361B2 (en)	2010-03-02	2013-11-05	Concert Pharmaceuticals Inc.	Tetrahydronaphthalene derivatives
US8513434B2 (en)	2010-03-02	2013-08-20	Concert Pharmaceuticals Inc.	Tetrahydronaphthalene derivatives
WO2012009446A1 (en)	2010-07-16	2012-01-19	Concert Pharmaceuticals Inc.	Novel pyrimidinecarboxamide derivatives
WO2012024595A2 (en) *	2010-08-20	2012-02-23	University Of Washington	Circumferential aerosol device for delivering drugs to olfactory epithelium and brain
US20120048963A1 (en)	2010-08-26	2012-03-01	Alexza Pharmaceuticals, Inc.	Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
HRP20211762T1 (hr)	2010-09-07	2022-02-18	Anacor Pharmaceuticals, Inc.	Derivati benzoksaborola za liječenje bakterijskih infekcija
DE102010041840A1 (de) *	2010-10-01	2012-04-05	Bayerische Motoren Werke Aktiengesellschaft	Verfahren zur Herstellung einer Ventilationsbohrung in einem Lagerstuhl eines Kurbelgehäuses einer Hubkolben-Brennkraftmaschine
WO2012079075A1 (en)	2010-12-10	2012-06-14	Concert Pharmaceuticals, Inc.	Deuterated phthalimide derivatives
EP2654864B1 (en)	2010-12-22	2020-10-28	Syqe Medical Ltd.	System for drug delivery
US8447329B2 (en)	2011-02-08	2013-05-21	Longsand Limited	Method for spatially-accurate location of a device using audio-visual information
CA2828884C (en)	2011-03-03	2021-04-27	Impel Neuropharma, Inc.	Nasal drug delivery device
WO2012129381A1 (en)	2011-03-22	2012-09-27	Concert Pharmaceuticals Inc.	Deuterated preladenant
US20140213553A1 (en)	2011-05-03	2014-07-31	Concert Pharmaceuticals Inc.	Carbamoylpyridone derivatives
WO2012154859A1 (en)	2011-05-09	2012-11-15	Impel Neuropharma Inc.	Nozzles for nasal drug delivery
US20140072621A1 (en)	2011-05-09	2014-03-13	The Cleveland Clinic Foundation	Composition and method to improve intestinal health
WO2012154728A1 (en)	2011-05-10	2012-11-15	Concert Pharmaceuticals Inc.	Deuterated n-butyl bumetanide
ES2758028T3 (es)	2011-05-18	2020-05-04	Vertex Pharmaceuticals Europe Ltd	Derivados deuterados de ivacaftor
CA2860740A1 (en)	2012-01-09	2013-07-18	Anchor Therapeutics, Inc.	Apj receptor compounds
WO2013130849A1 (en)	2012-02-29	2013-09-06	Concert Pharmaceuticals, Inc.	Substituted dioxopiperidinyl phthalimide derivatives
US20150066550A1 (en) *	2012-03-30	2015-03-05	Nec Corporation	Flow line data analysis device, system, non-transitory computer readable medium and method
IN2014DN08443A (ja)	2012-04-13	2015-05-08	Concert Pharmaceuticals Inc
US9249093B2 (en)	2012-04-20	2016-02-02	Concert Pharmaceuticals, Inc.	Deuterated rigosertib
EA201492287A1 (ru)	2012-06-15	2015-07-30	Консерт Фармасьютикалс, Инк.	Дейтерированные производные руксолитиниба
CA2908929C (en)	2012-07-12	2021-01-26	Concert Pharmaceuticals, Inc.	Deuterated idebenone
MX361499B (es)	2012-08-17	2018-12-06	Concert Pharmaceuticals Inc	Baricitinib deuterado.
EP2711006A1 (en)	2012-09-21	2014-03-26	Basil Rigas	Product Comprising a Nicotine-Containing Material and an Anti-Cancer Agent
WO2014078842A1 (en)	2012-11-19	2014-05-22	Concert Pharmaceuticals, Inc.	Deuterated cftr potentiators
US10034988B2 (en)	2012-11-28	2018-07-31	Fontem Holdings I B.V.	Methods and devices for compound delivery
US9795752B2 (en)	2012-12-03	2017-10-24	Mhs Care-Innovation, Llc	Combination respiratory therapy device, system, and method
US12080401B2 (en)	2012-12-03	2024-09-03	Metrohealth Ventures Llc	Combination respiratory therapy device, system and method
US9757529B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
MX2015008187A (es)	2012-12-20	2016-02-05	Concert Pharmaceuticals Inc	Inhibidores de alk deuterados.
US9757395B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
WO2014110322A2 (en)	2013-01-11	2014-07-17	Concert Pharmaceuticals, Inc.	Substituted dioxopiperidinyl phthalimide derivatives
US9186860B2 (en) *	2013-01-28	2015-11-17	Carl D. Luenser	Vaporizer kit for tobacco, medications, and the like
AU2014235462C1 (en)	2013-03-15	2018-11-01	Concert Pharmaceuticals, Inc.	Deuterated palbociclib
EP2968268B1 (en)	2013-03-15	2020-07-29	Concert Pharmaceuticals Inc.	Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
US11554229B2 (en)	2013-03-26	2023-01-17	OptiNose Inc.	Nasal administration
HU231191B1 (hu)	2013-04-15	2021-08-30	Szegedi Tudományegyetem	Izotóp tartalmú morfin molekulák
US10537692B2 (en)	2013-04-28	2020-01-21	Impel Neuropharma, Inc.	Medical unit dose container
JP2016518388A (ja)	2013-04-30	2016-06-23	オティトピックインク．	乾燥粉末配合および使用方法
US9549909B2 (en)	2013-05-03	2017-01-24	The Katholieke Universiteit Leuven	Method for the treatment of dravet syndrome
CN104274427A (zh) *	2013-07-03	2015-01-14	陆克塞纳医药公司	格拉司琼气溶胶组合物及其用途
CN104274426A (zh)	2013-07-03	2015-01-14	陆克塞纳医药公司	昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
CA3061122C (en)	2013-07-11	2023-10-17	Alexza Pharmaceuticals, Inc.	Nicotine salt with meta-salicylic acid
WO2015010045A1 (en)	2013-07-18	2015-01-22	Anchor Therapeutics, Inc.	Apj receptor compounds
WO2015009889A1 (en)	2013-07-18	2015-01-22	Concert Pharmaceuticals, Inc.	Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
MX348595B (es)	2013-08-02	2017-06-21	Laboratorio Raam De Sahuayo S A De C V	Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
US9676790B2 (en)	2013-08-30	2017-06-13	Concert Pharmaceuticals, Inc.	Substituted thienotriazolodiazapines
US10194693B2 (en)	2013-09-20	2019-02-05	Fontem Holdings 1 B.V.	Aerosol generating device
US9364815B2 (en) *	2013-11-07	2016-06-14	Saudi Basic Industries Corporation	Method of preparing an alumina catalyst support and catalyst for dehydrogenation reactions, and its use
CA2875384A1 (en)	2013-12-20	2015-06-20	AntiOP, Inc.	Intranasal naloxone compositions and methods of making and using same
EP3086793B1 (en)	2013-12-24	2022-05-11	Virginia Commonwealth University	Use of oxygenated cholesterol sulfates (ocs) for the treatment of kidney dysfunction
EA030907B1 (ru)	2013-12-24	2018-10-31	Президент Энд Феллоус Оф Гарвард Колледж	Аналоги кортистатина, их синтез и применения
US10821240B2 (en)	2014-02-11	2020-11-03	Vapor Cartridge Technology Llc	Methods and drug delivery devices using cannabis
US9220294B2 (en)	2014-02-11	2015-12-29	Timothy McCullough	Methods and devices using cannabis vapors
US9380813B2 (en)	2014-02-11	2016-07-05	Timothy McCullough	Drug delivery system and method
CA2977083A1 (en)	2014-02-20	2015-08-27	Kambiz Yadidi	Dry powder formulations for inhalation
AU2015229661B2 (en) *	2014-03-10	2019-05-30	Tiger Tool International Incorporated	Heating and cooling systems and methods for truck cabs
WO2015148649A2 (en) *	2014-03-26	2015-10-01	Basil Rigas	Systems and methods for ameliorating the effects of tobacco products
US20170027963A1 (en) *	2014-04-10	2017-02-02	Patrick Crowley	Delivery of non-steroidal agents to the brain via the nasal tract to treat neurological disorders
WO2015179772A1 (en)	2014-05-23	2015-11-26	Concert Pharmaceuticals, Inc.	Deuterated phenylquinazolinone and phenylisoquinolinone compounds
MA39999A (fr)	2014-06-06	2015-12-10	Res Triangle Inst	Agonistes du récepteur de l'apeline (apj) et leurs utilisations
JP2015229527A (ja) *	2014-06-09	2015-12-21	三光機械株式会社	多列式自動包装機
MX378843B (es)	2014-06-30	2025-03-10	Syqe Medical Ltd	Cartucho de dosis de farmaco para un dispositivo inhalador.
US11298477B2 (en)	2014-06-30	2022-04-12	Syqe Medical Ltd.	Methods, devices and systems for pulmonary delivery of active agents
EP3160565B1 (en)	2014-06-30	2021-08-18	Syqe Medical Ltd.	Devices and systems for pulmonary delivery of active agents
MX2017000057A (es)	2014-06-30	2017-06-30	Syqe Medical Ltd	Procedimiento y dispositivo para vaporizacion e inhalacion de sustancias aisladas.
CN106604755B (zh)	2014-06-30	2020-08-11	Syqe医药有限公司	流量调节的吸入器装置
WO2016001922A1 (en)	2014-06-30	2016-01-07	Syqe Medical Ltd.	Methods, devices and systems for pulmonary delivery of active agents
NZ730560A (en)	2014-09-29	2020-05-29	Zogenix International Ltd	Control system for control of distribution of medication
WO2016061488A1 (en)	2014-10-17	2016-04-21	Concert Pharmaceuticals, Inc.	Amine reuptake inhibitors
WO2016073545A1 (en)	2014-11-06	2016-05-12	Concert Pharmaceuticals, Inc.	Phenyloxadiazole benzoic acids
WO2016089814A1 (en)	2014-12-02	2016-06-09	Concert Pharmaceuticals, Inc.	Deuterated analogues of daclatasvir
US11058856B2 (en)	2014-12-23	2021-07-13	Acelrx Pharmaceuticals, Inc.	Systems, devices and methods for dispensing oral transmucosal dosage forms
WO2016105547A1 (en)	2014-12-24	2016-06-30	Concert Pharmaceuticals, Inc.	Deuterated dasabuvir
WO2016109795A1 (en)	2014-12-31	2016-07-07	Concert Pharmaceuticals, Inc.	Deuterated funapide and difluorofunapide
US20160206610A1 (en) *	2015-01-20	2016-07-21	Xoc Pharmaceuticals, Inc.	Methods for treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or acute emesis and/or delayed emesis
BR112017015487A2 (pt)	2015-01-20	2018-01-30	Xoc Pharmaceuticals Inc	Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
CA2974113A1 (en)	2015-01-20	2016-07-28	Xoc Pharmaceuticals, Inc.	Isoergoline compounds and uses thereof
WO2016144830A1 (en)	2015-03-06	2016-09-15	Concert Pharmaceuticals, Inc.	Deuterated emricasan
CN107750177B (zh)	2015-03-11	2022-03-11	艾利斯达医药品公司	气道中的防静电材料用于热气溶胶凝结方法的用途
AU2016243171B2 (en)	2015-03-31	2020-10-08	Concert Pharmaceuticals, Inc.	Deuterated VX-661
EP4186548A1 (en)	2015-04-02	2023-05-31	Hill-Rom Services PTE. LTD.	Mask leakage detection for a respiratory device
MD3283067T2 (ro) *	2015-04-14	2020-05-31	Milestone Pharmaceuticals Inc	Săruri cu solubilitate mare în apă, cu acțiune scurtă a fenilalchilaminei ca blocant al canalului de calciu, și utilizarea acestora
US10683305B2 (en)	2015-04-27	2020-06-16	Concert Pharmaceuticals, Inc.	Deuterated OTX-015
EP3294298A4 (en)	2015-05-08	2018-10-17	President and Fellows of Harvard College	Cortistatin analogues, syntheses, and uses thereof
WO2017003469A1 (en) *	2015-06-30	2017-01-05	University Of South Florida	Inhibitors of the fkbp51 protein from a high-throughput drug screen and methods of use
WO2017004411A1 (en)	2015-07-01	2017-01-05	President And Fellows Of Harvard College	Cortistatin analogues and syntheses and uses thereof
US10034857B2 (en)	2015-07-02	2018-07-31	Civitas Therapeutics, Inc.	Triptan powders for pulmonary delivery
WO2017020005A1 (en)	2015-07-30	2017-02-02	Concert Pharmaceuticals, Inc.	Morphinan compounds for use in treating agitation
WO2017020002A1 (en)	2015-07-30	2017-02-02	Concert Pharmaceuticals, Inc.	Deuterated morphinan compounds for use in treating agitation
AU2016321345B2 (en)	2015-09-10	2020-12-10	Impel Pharmaceuticals Inc.	In-line nasal delivery device
EP3377179B1 (en)	2015-11-19	2021-04-07	Concert Pharmaceuticals Inc.	Deuterated epi-743
EP3386976A1 (en)	2015-12-09	2018-10-17	Research Triangle Institute, International	Improved apelin receptor (apj) agonists and uses thereof
WO2017112701A1 (en)	2015-12-22	2017-06-29	Zogenix International Limited	Metabolism resistant fenfluramine analogs and methods of using the same
HRP20250898T1 (hr) *	2015-12-22	2025-09-26	Zogenix International Limited	Pripravci fenfluramina i postupci njihove pripreme
US10092036B2 (en) *	2015-12-28	2018-10-09	Rai Strategic Holdings, Inc.	Aerosol delivery device including a housing and a coupler
ES2874087T3 (es)	2016-01-06	2021-11-04	Syqe Medical Ltd	Tratamiento terapéutico con dosis bajas
CA3012333A1 (en)	2016-02-01	2017-08-10	Incarda Therapeutics, Inc.	Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation
US20170216220A1 (en) *	2016-02-03	2017-08-03	Intelgenx Corp.	Loxapine film oral dosage form
WO2017147003A1 (en)	2016-02-26	2017-08-31	Novobiotic Pharmaceuticals, Llc	Novel macrocyclic antibiotics and uses thereof
CA3027505A1 (en)	2016-06-15	2017-12-21	The General Hospital Corporation	Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
EP3825307B1 (en)	2016-07-04	2022-08-03	Avanir Pharmaceuticals, Inc.	Methods for the synthesis of deuterated dextromethorphan
WO2018026833A1 (en)	2016-08-01	2018-02-08	The Brigham And Women's Hospital, Inc.	Particles for delivery of proteins and peptides
JP2019526544A (ja)	2016-08-24	2019-09-19	ゾゲニクスインターナショナルリミテッド	５−ｈｔ２ｂアゴニストの形成を阻害するための製剤およびその使用方法
DE102016221705B4 (de)	2016-11-07	2018-05-17	Schaeffler Technologies AG & Co. KG	Zahnrad aus einem Zahnradverbund und Verfahren zur Herstellung eines Zahnradverbundes
US20180185347A1 (en) *	2016-11-16	2018-07-05	Transition Therapeutics (Ireland 2) Limited	Tetrahydrocyclopenta[b]indole compounds and phosphodiesterase inhibitors for the treatment of the signs and symptoms of bhp
LT3551189T (lt)	2016-12-09	2024-02-12	Alexza Pharmaceuticals, Inc.	Alprazolamas, skirtas vartoti gydant epilepsiją
US10696677B2 (en)	2016-12-21	2020-06-30	Research Triangle Institute	Diaryl purine derivatives with improved bioavailability
MX381932B (es)	2017-02-02	2025-03-13	Otolanum Ag	Composicion intranasal que comprende betahistina.
EP3589659B1 (en)	2017-02-28	2025-04-09	Mayo Foundation for Medical Education and Research	Combinations for use in the treatment of cancer
SI3592393T1 (sl)	2017-03-10	2022-04-29	Quiapeg Pharmaceuticals Ab	Sprostljivi konjugati
SG11201908420WA (en)	2017-03-13	2019-10-30	Beyondspring Pharmaceuticals Inc	Compositions of plinabulin and use thereof
WO2018209107A1 (en)	2017-05-10	2018-11-15	Incarda Therapeutics, Inc.	Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
US11278025B2 (en)	2017-05-17	2022-03-22	The General Hospital Corporation	Antibiotic compounds
PH12019502544B1 (en)	2017-05-19	2023-07-26	Superb Wisdom Ltd	Derivatives of resiquimod
CA3064274A1 (en)	2017-06-01	2018-12-06	Xoc Pharmaceuticals, Inc.	Ergoline derivatives for use in medicine
WO2018232252A1 (en)	2017-06-15	2018-12-20	Mayo Foundation For Medical Education And Research	Methods to treat gliomas using a stat3 inhibitor
WO2018232251A1 (en)	2017-06-16	2018-12-20	The General Hospital Corporation	Tricyclic compounds as cyp1 inhibitors
US9993486B1 (en)	2017-06-19	2018-06-12	Tlc Therapeutics, Llc	Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
CN109391578B (zh) *	2017-08-11	2022-07-22	华为技术有限公司	信号发送方法、信号接收方法、终端设备及网络设备
US10682317B2 (en)	2017-09-26	2020-06-16	Zogenix International Limited	Ketogenic diet compatible fenfluramine formulation
WO2019079297A1 (en)	2017-10-16	2019-04-25	Dana-Farber Cancer Institute, Inc.	COMPOUNDS AND METHODS OF TREATING CANCER
EP3700527A4 (en)	2017-10-25	2021-03-10	Children's Medical Center Corporation	PAPD5 INHIBITORS AND METHOD OF USING THEM
EP3713628A4 (en)	2017-11-21	2021-08-18	Impel Neuropharma Inc.	INTRA-NASAL DEVICE WITH DIVER TUBE
US11395887B2 (en)	2017-11-21	2022-07-26	Impel Pharmaceuticals Inc.	Intranasal device with inlet interface
EP3735244B1 (en)	2018-01-05	2022-11-23	Impel Pharmaceuticals Inc.	Intranasal delivery of dihydroergotamine by precision olfactory device
CA3087698A1 (en)	2018-01-05	2019-07-11	Impel Neuropharma, Inc.	Intranasal delivery of olanzapine by precision olfactory device
CA3089864A1 (en)	2018-01-31	2019-08-08	Mayo Foundation For Medical Education And Research	Methods of treating fibrotic pathologies
US12214118B2 (en)	2018-02-02	2025-02-04	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device
ES3040411T3 (en)	2018-03-22	2025-10-30	Incarda Therapeutics Inc	A novel method to slow ventricular rate
WO2019216919A1 (en)	2018-05-11	2019-11-14	Zogenix International Limited	Compositions and methods for treating seizure-induced sudden death
MX384760B (es)	2018-07-04	2025-03-14	Federico Amezcua Amezcua	Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático.
CA3104521A1 (en)	2018-07-05	2020-01-09	Mayo Foundation For Medical Education And Research	Pikfyve inhibitors
CN112955134A (zh)	2018-07-19	2021-06-11	英倍尔药业股份有限公司	用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送
US12290526B2 (en)	2018-08-13	2025-05-06	Federico Amezcua Amezcua	Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses
US11083850B2 (en)	2018-08-21	2021-08-10	Vivera Pharmaceuticals Inc.	Secure smart dosing system with automated delivery, measurement, and management
US11090449B2 (en)	2018-08-21	2021-08-17	Vivera Pharmaceuticals Inc.	Smart inhaler device with automated dose delivery, measurement, and management
AU2019340472A1 (en)	2018-09-12	2021-04-01	Quiapeg Pharmaceuticals Ab	Releasable GLP-1 conjugates
SG11202104378SA (en)	2018-11-19	2021-05-28	Zogenix International Ltd	Methods of treating rett syndrome using fenfluramine
NZ777687A (en)	2019-01-03	2023-12-22	Impel Pharmaceuticals Inc	Nasal drug delivery device
AU2020204717B2 (en)	2019-01-03	2025-01-16	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Methods and materials for increasing transcription factor EB polypeptide levels
MX2019000312A (es)	2019-01-08	2019-10-09	Federico Amezcua Amezcua	Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.
CN109674773A (zh) *	2019-02-22	2019-04-26	南京中医药大学	一种肺部给药的昔多芬药物微粒及其制备方法与应用
WO2020219729A1 (en)	2019-04-24	2020-10-29	Children's Medical Center Corporation	Papd5 inhibitors and methods of use thereof
AU2020277313A1 (en)	2019-05-17	2022-01-20	Impel Pharmaceuticals Inc.	Single-use nasal delivery device
EP3982942A4 (en)	2019-06-17	2023-06-07	Mayo Foundation for Medical Education and Research	METHODS OF DELIVERY OF THE AGENTS AND COMPOSITIONS
EP4378532B1 (en)	2019-07-30	2025-11-12	Mayo Foundation for Medical Education and Research	Compounds and methods for treating fibrotic pathologies
US11007185B2 (en)	2019-08-01	2021-05-18	Incarda Therapeutics, Inc.	Antiarrhythmic formulation
US11364225B2 (en)	2019-08-21	2022-06-21	Bn Intellectual Properties, Inc.	Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
EP4027987A4 (en)	2019-09-10	2023-11-29	University of Pittsburgh - Of the Commonwealth System of Higher Education	Methods and materials for increasing level of phosphorylated ampk protein
EP4030941A1 (en)	2019-09-16	2022-07-27	Vapor Cartridge Technology LLC	Drug delivery system with stackable substrates
US12070554B2 (en)	2019-11-11	2024-08-27	Hill-Rom Services Pte. Ltd.	Pneumatic connector apparatus and method
CN115397419B (zh) *	2020-02-14	2025-11-14	帝国制药美国公司	外用纳洛酮组合物及其使用方法
EP3868364A1 (en)	2020-02-24	2021-08-25	GH Research Limited	Aerosol comprising 5-methoxy-n,n-dimethyltryptamine
CA3184471A1 (en)	2020-05-27	2021-12-02	The Penn State Research Foundation	Antibacterial compounds
US11612574B2 (en)	2020-07-17	2023-03-28	Zogenix International Limited	Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
US11071739B1 (en)	2020-09-29	2021-07-27	Genus Lifesciences Inc.	Oral liquid compositions including chlorpromazine
US20220117916A1 (en) *	2020-10-19	2022-04-21	SafeRx Pharmaceuticals, LLC	Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose
EP4351574A4 (en)	2021-06-07	2025-04-02	The General Hospital Corporation	Inhibitors of ttbk1
EP4159192A1 (en)	2021-09-30	2023-04-05	Biomind Labs Inc	Dimethyltriptamine-based nasal spray for the personalised treatment of neurological and psychiatric disorders
TW202325285A (zh) *	2021-10-14	2023-07-01	靜岡縣公立大學法人	粉末製劑
WO2023096886A1 (en)	2021-11-23	2023-06-01	Mayo Foundation For Medical Education And Research	Enhancers of particulate guanylyl cyclase receptor a
IT202100031637A1 (it)	2021-12-17	2023-06-17	Universita’ Degli Studi Di Parma	Polveri per inalazione e procedimento di produzione
EP4349175A1 (en)	2022-10-05	2024-04-10	The Procter & Gamble Company	Antimicrobial composition comprising a modified alkyl glycoside and an organic acid

Family Cites Families (279)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US30285A (en) *		1860-10-09		Fruit-drier
US113557A (en) *		1871-04-11		Improvement in metal screws and nuts
US32638A (en) *		1861-06-25		Boot-heel
US58009A (en) *		1866-09-11		Improved condenser
GB502761A (en)	1938-01-29	1939-03-24	Christopher Engelbreth	Improvements in and relating to hand inhalation apparatus
US2902484A (en)	1954-04-27	1959-09-01	Rhone Poulenc Sa	Phenthiazine derivatives and processes for their preparation
US3474101A (en)	1960-09-05	1969-10-21	Reckitt & Sons Ltd	Thebaine and oripavine derivatives
NL135583C (ja)	1961-10-10
GB972363A (en)	1962-08-18	1964-10-14	Rambold Adolf	Wrapper band for teabag or the like
US3169095A (en)	1962-10-30	1965-02-09	Rexall Drug Chemical	Self-propelling powder-dispensing compositions
BE629985A (ja)	1962-11-29
GB1063512A (en)	1962-11-30	1967-03-30	Benger Lab Ltd	Aerosols
US3456247A (en) *	1966-01-14	1969-07-15	Ibm	Coupled film storage device
IL26896A (en)	1966-01-19	1970-11-30	Endo Lab	14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US3987052A (en)	1969-03-17	1976-10-19	The Upjohn Company	6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
USRE30285E (en)	1972-05-22	1980-05-27		Spraying devices, in particular nebulizing devices
US3949743A (en)	1973-03-19	1976-04-13	Schick Incorporated	Medicated vapor production method and apparatus
US3982095A (en)	1973-10-04	1976-09-21	Searle Cardio-Pulmonary Systems Inc.	Respiratory humidifier
US3894040A (en)	1974-09-16	1975-07-08	American Home Prod	2,5,6,7-Tetrahydro-3H-imidazo(1,2-D)(1,4)benzodiazepine-5,6-dicarboxylic acid esters
US4121583A (en)	1976-07-13	1978-10-24	Wen Yuan Chen	Method and apparatus for alleviating asthma attacks
US4141369A (en)	1977-01-24	1979-02-27	Burruss Robert P	Noncombustion system for the utilization of tobacco and other smoking materials
SE7812207L (sv)	1977-12-01	1979-06-02	Welsh Nat School Med	Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer
US4183912A (en)	1978-01-16	1980-01-15	American Home Products Corporation	Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
US4484451A (en) *	1978-09-05	1984-11-27	United Air Specialists, Inc.	Two-stage gas condenser with feedback cooling
IL59407A (en)	1979-03-06	1983-12-30	Sanofi Sa	Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
US4654370A (en)	1979-03-12	1987-03-31	Abbott Laboratories	Glyceryl valproates
US4229447A (en)	1979-06-04	1980-10-21	American Home Products Corporation	Intraoral methods of using benzodiazepines
ATE3774T1 (de)	1980-05-02	1983-06-15	Schering Corporation	Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
US4303083A (en)	1980-10-10	1981-12-01	Burruss Jr Robert P	Device for evaporation and inhalation of volatile compounds and medications
US4376767A (en)	1981-01-02	1983-03-15	Merck & Co., Inc.	Pyridylmethyl esters of selected bio-affecting carboxylic acids
DE3116951C2 (de)	1981-04-29	1984-12-20	Drägerwerk AG, 2400 Lübeck	Vorrichtung zur Beimischung flüssiger Narkosemittel in das dem Patienten zuzuführende Atemgas
DE3224849A1 (de)	1982-07-02	1984-01-05	Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn	Dampfinhaliergeraet
US4508726A (en)	1982-09-16	1985-04-02	The Upjohn Company	Treatment of panic disorders with alprazolam
US4474191A (en)	1982-09-30	1984-10-02	Steiner Pierre G	Tar-free smoking devices
CH665750A5 (de)	1982-09-30	1988-06-15	Dainippon Jochugiku Kk	Beheizbarer wirkstoffverdampfer.
US4753758A (en)	1983-05-19	1988-06-28	Intertech Resources Inc.	Respiratory humidifier
DE3326089A1 (de)	1983-07-20	1985-02-07	Gödecke AG, 1000 Berlin	Zur inhalation bestimmte darreichungsform von calcium-antagonisten
EP0133795B1 (en)	1983-08-01	1989-01-18	THE McLEAN HOSPITAL CORPORATION	Gaba esters and gaba analogue esters
US4588721A (en)	1983-09-12	1986-05-13	The Upjohn Company	Treatment of negative symptoms of schizophrenia
US4566552A (en) *	1983-11-16	1986-01-28	International Harvester Company	Hood tilt retardation system
US4683231A (en)	1984-03-02	1987-07-28	Research Foundation For Mental Hygiene, Inc.	Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking
US5020548A (en)	1985-08-26	1991-06-04	R. J. Reynolds Tobacco Company	Smoking article with improved fuel element
US4793365A (en)	1984-09-14	1988-12-27	R. J. Reynolds Tobacco Company	Smoking article
US5042509A (en)	1984-09-14	1991-08-27	R. J. Reynolds Tobacco Company	Method for making aerosol generating cartridge
US4854331A (en)	1984-09-14	1989-08-08	R. J. Reynolds Tobacco Company	Smoking article
US5067499A (en)	1984-09-14	1991-11-26	R. J. Reynolds Tobacco Company	Smoking article
CN1018607B (zh)	1984-12-21	1992-10-14	美国耳·杰·瑞诺兹烟草公司	吸烟制品
US4928714A (en)	1985-04-15	1990-05-29	R. J. Reynolds Tobacco Company	Smoking article with embedded substrate
AU587472B2 (en)	1985-05-22	1989-08-17	Liposome Technology, Inc.	Liposome inhalation method and system
US4989619A (en)	1985-08-26	1991-02-05	R. J. Reynolds Tobacco Company	Smoking article with improved fuel element
US4756318A (en)	1985-10-28	1988-07-12	R. J. Reynolds Tobacco Company	Smoking article with tobacco jacket
US5033483A (en)	1985-10-28	1991-07-23	R. J. Reynolds Tobacco Company	Smoking article with tobacco jacket
US5060666A (en)	1985-10-28	1991-10-29	R. J. Reynolds Tobacco Company	Smoking article with tobacco jacket
JPS62204756A (ja) *	1986-03-04	1987-09-09	大研医工株式会社	薬剤揮散方法および装置
EP0259383B1 (de)	1986-03-10	1991-01-23	Kurt Dr. Burghart	Pharmazeutikum sowie verfahren zu seiner herstellung
US4708151A (en)	1986-03-14	1987-11-24	R. J. Reynolds Tobacco Company	Pipe with replaceable cartridge
US4771795A (en)	1986-05-15	1988-09-20	R. J. Reynolds Tobacco Company	Smoking article with dual burn rate fuel element
US4917120A (en)	1986-05-21	1990-04-17	Advanced Tobacco Products, Inc.	Nicotine impact modification
US4735217A (en) *	1986-08-21	1988-04-05	The Procter & Gamble Company	Dosing device to provide vaporized medicament to the lungs as a fine aerosol
US4858630A (en)	1986-12-08	1989-08-22	R. J. Reynolds Tobacco Company	Smoking article with improved aerosol forming substrate
US4734560A (en)	1987-01-20	1988-03-29	Medical Enterprises, Ltd.	Vaporizing unit
US4819665A (en)	1987-01-23	1989-04-11	R. J. Reynolds Tobacco Company	Aerosol delivery article
US4924883A (en)	1987-03-06	1990-05-15	R. J. Reynolds Tobacco Company	Smoking article
US5017575A (en)	1987-06-09	1991-05-21	Golwyn Daniel H	Treatment of immunologically based disorders, specifically Crohn's disease
GB8713645D0 (en)	1987-06-11	1987-07-15	Imp Tobacco Ltd	Smoking device
US5019122A (en)	1987-08-21	1991-05-28	R. J. Reynolds Tobacco Company	Smoking article with an enclosed heat conductive capsule containing an aerosol forming substance
US4906417A (en)	1988-02-08	1990-03-06	Associated Mills Inc.	Humidifier
US4853517A (en)	1988-03-28	1989-08-01	John G. Bowen	Vaporizing unit
US4906119A (en) *	1988-04-14	1990-03-06	Lloyd Hartford	Handwriting stabilizer
DE3815221C2 (de)	1988-05-04	1995-06-29	Gradinger F Hermes Pharma	Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US4881556A (en)	1988-06-06	1989-11-21	R. J. Reynolds Tobacco Company	Low CO smoking article
US5345951A (en)	1988-07-22	1994-09-13	Philip Morris Incorporated	Smoking article
EP0358114A3 (en)	1988-09-08	1990-11-14	R.J. Reynolds Tobacco Company	Aerosol delivery articles utilizing electrical energy
US4947875A (en)	1988-09-08	1990-08-14	R. J. Reynolds Tobacco Company	Flavor delivery articles utilizing electrical energy
US4922901A (en)	1988-09-08	1990-05-08	R. J. Reynolds Tobacco Company	Drug delivery articles utilizing electrical energy
US4947874A (en)	1988-09-08	1990-08-14	R. J. Reynolds Tobacco Company	Smoking articles utilizing electrical energy
USRE36744E (en)	1988-09-16	2000-06-20	Ribogene, Inc.	Nasal administration of benzodiazepine hypnotics
US4950664A (en)	1988-09-16	1990-08-21	Rugby-Darby Group Companies, Inc.	Nasal administration of benzodiazepine hypnotics
US4963289A (en)	1988-09-19	1990-10-16	The United States Of America As Represented By The United States Department Of Energy	Method for producing monodisperse aerosols
US5511726A (en)	1988-09-23	1996-04-30	Battelle Memorial Institute	Nebulizer device
US4917119A (en)	1988-11-30	1990-04-17	R. J. Reynolds Tobacco Company	Drug delivery article
US4906476A (en)	1988-12-14	1990-03-06	Liposome Technology, Inc.	Novel liposome composition for sustained release of steroidal drugs in lungs
GB8900267D0 (en)	1989-01-06	1989-03-08	Riker Laboratories Inc	Narcotic analgesic formulations and apparatus containing same
DE3908161A1 (de)	1989-03-13	1990-09-27	Bat Cigarettenfab Gmbh	Rauchbarer artikel
JP3062760B2 (ja) *	1989-03-14	2000-07-12	コニカ株式会社	複合レンズ
CA2058764A1 (en)	1989-04-28	1990-10-29	Peter D. Hodson	Dry powder inhalation device
CA2054197A1 (en)	1989-05-05	1990-11-06	Christopher O'neill	Fertility enhancement
ES2046368T3 (es) *	1989-05-17	1994-02-01	Leifeld Gmbh & Co.	Procedimiento para la fabricacion de una polea.
US4941483A (en)	1989-09-18	1990-07-17	R. J. Reynolds Tobacco Company	Aerosol delivery article
US6048857A (en)	1989-10-17	2000-04-11	Ellinwood, Jr.; Everett H.	Dosing method of administering medicaments via inhalation administration
US6313176B1 (en)	1989-10-17	2001-11-06	Everett J. Ellinwood, Jr.	Dosing method of administering deprenyl via intraoral administration or inhalation administration
US5707644A (en) *	1989-11-04	1998-01-13	Danbiosyst Uk Limited	Small particle compositions for intranasal drug delivery
US5224498A (en)	1989-12-01	1993-07-06	Philip Morris Incorporated	Electrically-powered heating element
US5060671A (en)	1989-12-01	1991-10-29	Philip Morris Incorporated	Flavor generating article
US5144962A (en)	1989-12-01	1992-09-08	Philip Morris Incorporated	Flavor-delivery article
ATE156704T1 (de)	1989-12-05	1997-08-15	Ramsey Foundation	Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
GB2239807A (en)	1990-01-09	1991-07-17	Boc Group Plc	Anaesthetic vaporiser
US5376386A (en)	1990-01-24	1994-12-27	British Technology Group Limited	Aerosol carriers
US5099861A (en)	1990-02-27	1992-03-31	R. J. Reynolds Tobacco Company	Aerosol delivery article
US5366770A (en)	1990-04-17	1994-11-22	Xingwu Wang	Aerosol-plasma deposition of films for electronic cells
US5455043A (en)	1990-06-13	1995-10-03	Fischel-Ghodsian; Fariba	Device for controlled release of vaporous medications through nasal route
US5126123A (en)	1990-06-28	1992-06-30	Glaxo, Inc.	Aerosol drug formulations
ES2073685T5 (es)	1990-08-02	2002-03-01	Datex Ohmeda Inc	Vaporizador de anestesico.
US5292499A (en)	1990-09-11	1994-03-08	University Of Wales College Of Cardiff	Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
US5166202A (en)	1990-09-19	1992-11-24	Trustees Of The University Of Pennsylvania	Method for the treatment of panic disorder
US5175152A (en)	1990-09-28	1992-12-29	Singh Nikhilesh N	Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US5343226A (en) *	1990-09-28	1994-08-30	Dataproducts Corporation	Ink jet ink supply apparatus
ATE179605T1 (de)	1991-02-09	1999-05-15	B S D Bio Science Dev Snc Di O	Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation
US5993805A (en)	1991-04-10	1999-11-30	Quadrant Healthcare (Uk) Limited	Spray-dried microparticles and their use as therapeutic vehicles
US5457100A (en)	1991-12-02	1995-10-10	Daniel; David G.	Method for treatment of recurrent paroxysmal neuropsychiatric
US5639441A (en)	1992-03-06	1997-06-17	Board Of Regents Of University Of Colorado	Methods for fine particle formation
US5607691A (en)	1992-06-12	1997-03-04	Affymax Technologies N.V.	Compositions and methods for enhanced drug delivery
ATE204750T1 (de)	1992-06-12	2001-09-15	Teijin Ltd	Pharmazeutische zubereitung zur anwendung in den atemwegen
US5622944A (en)	1992-06-12	1997-04-22	Affymax Technologies N.V.	Testosterone prodrugs for improved drug delivery
US5284133A (en) *	1992-07-23	1994-02-08	Armstrong Pharmaceuticals, Inc.	Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
WO1994009842A1 (en) *	1992-10-28	1994-05-11	Rosen Charles A	Method and devices for delivering drugs by inhalation
US5724957A (en)	1993-01-29	1998-03-10	Aradigm Corporation	Intrapulmonary delivery of narcotics
US5558085A (en)	1993-01-29	1996-09-24	Aradigm Corporation	Intrapulmonary delivery of peptide drugs
US5694919A (en)	1993-01-29	1997-12-09	Aradigm Corporation	Lockout device for controlled release of drug from patient-activated dispenser
US5934272A (en)	1993-01-29	1999-08-10	Aradigm Corporation	Device and method of creating aerosolized mist of respiratory drug
US5507277A (en)	1993-01-29	1996-04-16	Aradigm Corporation	Lockout device for controlled release of drug from patient-activateddispenser
US5672581A (en)	1993-01-29	1997-09-30	Aradigm Corporation	Method of administration of insulin
US5915378A (en)	1993-01-29	1999-06-29	Aradigm Corporation	Creating an aerosolized formulation of insulin
US5357257A (en) *	1993-04-05	1994-10-18	General Electric Company	Apparatus and method for equalizing channels in a multi-channel communication system
US5497763A (en)	1993-05-21	1996-03-12	Aradigm Corporation	Disposable package for intrapulmonary delivery of aerosolized formulations
US5666977A (en)	1993-06-10	1997-09-16	Philip Morris Incorporated	Electrical smoking article using liquid tobacco flavor medium delivery system
CA2165961C (en)	1993-06-29	2005-08-30	Robert Martin Voges	Dispenser
US5388574A (en)	1993-07-29	1995-02-14	Ingebrethsen; Bradley J.	Aerosol delivery article
DE4328243C1 (de)	1993-08-19	1995-03-09	Sven Mielordt	Rauch- oder Inhalationsvorrichtung
US5456247A (en)	1993-08-26	1995-10-10	Iowa State University Research Foundation, Inc.	Method for delivering drugs soluble in a vaporization vehicle
FI98270C (fi)	1993-11-29	1997-05-26	Instrumentarium Oy	Menetelmä ja sovitelma anesteetin höyrystämisen yhteydessä
US5543434A (en)	1994-02-25	1996-08-06	Weg; Stuart L.	Nasal administration of ketamine to manage pain
US5451408A (en)	1994-03-23	1995-09-19	Liposome Pain Management, Ltd.	Pain management with liposome-encapsulated analgesic drugs
US6102036A (en)	1994-04-12	2000-08-15	Smoke-Stop	Breath activated inhaler
CA2189351C (en)	1994-05-13	2008-12-30	Stephen J. Farr	Narcotic containing aerosol formulation
US5522385A (en)	1994-09-27	1996-06-04	Aradigm Corporation	Dynamic particle size control for aerosolized drug delivery
IL115589A0 (en)	1994-10-14	1996-01-19	Glaxo Spa	Use of cck-b antagonists in pharmaceutical compositions
WO1996013292A1 (en)	1994-10-28	1996-05-09	Aradigm Corporation	Device and method of creating aerosolized mist of respiratory drug
US5767117A (en)	1994-11-18	1998-06-16	The General Hospital Corporation	Method for treating vascular headaches
JPH11502845A (ja)	1995-03-31	1999-03-09	アラディグムコーポレーション	造血剤の肺内輸送
US5758637A (en)	1995-08-31	1998-06-02	Aerogen, Inc.	Liquid dispensing apparatus and methods
US5612053A (en)	1995-04-07	1997-03-18	Edward Mendell Co., Inc.	Controlled release insufflation carrier for medicaments
US6258341B1 (en)	1995-04-14	2001-07-10	Inhale Therapeutic Systems, Inc.	Stable glassy state powder formulations
DE19519056A1 (de)	1995-05-24	1997-01-16	Klinge Co Chem Pharm Fab	Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation
US5874481A (en)	1995-06-07	1999-02-23	Alliance Pharmaceutical Corp.	Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US6245347B1 (en)	1995-07-28	2001-06-12	Zars, Inc.	Methods and apparatus for improved administration of pharmaceutically active compounds
JPH0943487A (ja)	1995-08-01	1997-02-14	Fuji Photo Film Co Ltd	ズームレンズ
US5649554A (en)	1995-10-16	1997-07-22	Philip Morris Incorporated	Electrical lighter with a rotatable tobacco supply
AU7669496A (en)	1995-11-03	1997-05-22	University Of Kentucky	Method for the intranasal administration of l-dopa prodrugs
US6017963A (en)	1995-11-14	2000-01-25	Euro-Celtique, S.A.	Formulation for intranasal administration
US5564442A (en)	1995-11-22	1996-10-15	Angus Collingwood MacDonald	Battery powered nicotine vaporizer
US6041777A (en) *	1995-12-01	2000-03-28	Alliance Pharmaceutical Corp.	Methods and apparatus for closed-circuit ventilation therapy
DK0870497T3 (da)	1995-12-14	2004-05-24	Taisho Pharmaceutical Co Ltd	Aerosolpræparat
SE9504580L (sv)	1995-12-21	1997-06-22	Siemens Elema Ab	Förfarande vid förgasning av en narkosvätska och en förgasare
EP0955885A1 (en)	1996-02-05	1999-11-17	Aradigm Corporation	Ventilation imaging using a fine particle aerosol generator
AUPN814496A0 (en)	1996-02-19	1996-03-14	Monash University	Dermal penetration enhancer
US5927124A (en) *	1996-03-05	1999-07-27	Adaptive Motion Control Systems, Inc.	Apparatus for bending and cutting tubing, and method of using same
GB9606188D0 (en)	1996-03-23	1996-05-29	Danbiosyst Uk	Pollysaccharide microspheres for the pulmonary delivery of drugs
GB2311949A (en)	1996-03-26	1997-10-15	Hadley Ind Plc	Rigid thin sheet material
GB9606677D0 (en)	1996-03-29	1996-06-05	Glaxo Wellcome Inc	Process and device
ES2205210T3 (es) *	1996-04-29	2004-05-01	Quadrant Technologies Ltd.	Procedimientos de inhalacion de polvos secos.
US5743251A (en)	1996-05-15	1998-04-28	Philip Morris Incorporated	Aerosol and a method and apparatus for generating an aerosol
US5874064A (en)	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
US5855913A (en)	1997-01-16	1999-01-05	Massachusetts Instite Of Technology	Particles incorporating surfactants for pulmonary drug delivery
GB9613015D0 (en)	1996-06-21	1996-08-28	Reckitt & Colman Inc	Device
EP1024833A1 (en)	1996-07-11	2000-08-09	Farmarc Nederland B.V.	Pharmaceutical composition containing acid addition salt of basic drug
US6131570A (en)	1998-06-30	2000-10-17	Aradigm Corporation	Temperature controlling device for aerosol drug delivery
US6694975B2 (en) *	1996-11-21	2004-02-24	Aradigm Corporation	Temperature controlling device for aerosol drug delivery
US5906202A (en)	1996-11-21	1999-05-25	Aradigm Corporation	Device and method for directing aerosolized mist to a specific area of the respiratory tract
EP0954282B1 (en)	1997-01-16	2005-01-19	Massachusetts Institute Of Technology	Preparation of particles for inhalation
US6461591B1 (en)	1997-02-05	2002-10-08	Jago Research Ag	Medical aerosol formulations
US5829435A (en)	1997-02-24	1998-11-03	Aradigm Corporation	Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles
US5837713A (en)	1997-02-26	1998-11-17	Mayo Foundation For Medical Education And Research	Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
KR100289448B1 (ko)	1997-07-23	2001-05-02	미즈노 마사루	향미발생장치
US5874841A (en) *	1997-07-28	1999-02-23	Philips Electronics North America Corporation	Sample-and-hold circuit for a switched-mode power supply
US6090212A (en)	1997-08-15	2000-07-18	Micro C Technologies, Inc.	Substrate platform for a semiconductor substrate during rapid high temperature processing and method of supporting a substrate
KR100575070B1 (ko)	1997-09-29	2006-05-03	넥타르 테라퓨틱스	안정화된 생활성 제제 및 이의 사용 방법
US6403597B1 (en) *	1997-10-28	2002-06-11	Vivus, Inc.	Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US5915841A (en) *	1998-01-05	1999-06-29	Capstone Turbine Corporation	Compliant foil fluid film radial bearing
US20020006181A1 (en)	1998-01-23	2002-01-17	Mackenzie Innes K.	Method and device for estimating bone mineral content of the calcaneus
US6158431A (en)	1998-02-13	2000-12-12	Tsi Incorporated	Portable systems and methods for delivery of therapeutic material to the pulmonary system
EP1080720A4 (en)	1998-03-05	2002-06-05	Nippon Shinyaku Co Ltd	FAT EMULSIONS FOR INHALATIVE ADMINISTRATION
DE69936848T2 (de)	1998-04-14	2008-05-15	The General Hospital Corp., Boston	Verwendung von d-serin oder d-alanin zur behandlung von schizophrenie
AU4680699A (en)	1998-06-12	1999-12-30	Aradigm Corporation	Methods of delivering aerosolized polynucleotides to the respiratory tract
US6095153A (en)	1998-06-19	2000-08-01	Kessler; Stephen B.	Vaporization of volatile materials
TWI223598B (en)	1998-06-22	2004-11-11	Pfizer Ireland Pharmaceuticals	An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
US6241969B1 (en)	1998-06-26	2001-06-05	Elan Corporation Plc	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
WO2000000215A1 (en)	1998-06-29	2000-01-06	Inhale Therapeutic Systems, Inc.	Particulate delivery systems and methods of use
GB9814172D0 (en)	1998-06-30	1998-08-26	Andaris Ltd	Formulation for inhalation
MA25590A1 (fr) *	1998-09-14	2002-12-31	Inhale Therapeutic Syst	Agent actif de delivraison de poudre seche
US6234167B1 (en)	1998-10-14	2001-05-22	Chrysalis Technologies, Incorporated	Aerosol generator and methods of making and using an aerosol generator
GB9823307D0 (en)	1998-10-23	1998-12-23	Regent Genus Organisms Interna	Composition for traetment of periodontopathy and related diseases
US6509005B1 (en)	1998-10-27	2003-01-21	Virginia Commonwealth University	Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
US6255334B1 (en) *	1998-10-30	2001-07-03	Pfizer Inc	5HT 1 receptor agonists and metoclopramide for the treatment of migraine
US7521068B2 (en)	1998-11-12	2009-04-21	Elan Pharma International Ltd.	Dry powder aerosols of nanoparticulate drugs
IL143046A0 (en)	1998-11-12	2002-04-21	Pilkiewicz Frank G	An inhalation system
RU2221552C2 (ru)	1998-11-13	2004-01-20	Джаго Рисерч Аг	Сухой порошок для ингаляции
US6070575A (en)	1998-11-16	2000-06-06	Aradigm Corporation	Aerosol-forming porous membrane with certain pore structure
CA2354576C (en) *	1998-12-11	2008-10-14	Pharmachemie B.V.	Pharmaceutical preparation for inhalation of an opioid
US6376550B1 (en)	1999-02-09	2002-04-23	Asta Medica Ag	Pharmaceutical compositions containing tramadol for migraine
AU2879100A (en)	1999-02-12	2000-08-29	Miles A. Libbey Iii	Formulation and system for intra-oral delivery of pharmaceutical agents
US6591839B2 (en) *	1999-02-17	2003-07-15	Dieter Meyer	Filter material for reducing harmful substances in tobacco smoke
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
AU4450700A (en)	1999-04-27	2000-11-10	Eli Lilly And Company	Insulin crystals for pulmonary administration
EP1173245B1 (en)	1999-05-03	2004-09-01	Battelle Memorial Institute	Compositions for aerosolization and inhalation
US6428769B1 (en)	1999-05-04	2002-08-06	Aradigm Corporation	Acute testosterone administration
GB9912356D0 (en)	1999-05-26	1999-07-28	Btg Int Ltd	Generation of microfoam
IL146659A0 (en)	1999-05-27	2002-07-25	Acusphere Inc	Porous drug matrices and method of manufacture thereof
WO2000076673A1 (en)	1999-06-11	2000-12-21	Aradigm Corporation	Method for producing an aerosol
US20020061281A1 (en)	1999-07-06	2002-05-23	Osbakken Robert S.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
WO2001005459A1 (en)	1999-07-16	2001-01-25	Aradigm Corporation	System for effecting smoke cessation
HK1047693A1 (zh) *	1999-08-13	2003-03-07	Vela Pharmaceuticals Inc.	治疗全身性焦虑障碍的环苯扎林及其组合物
JP2003507438A (ja)	1999-08-24	2003-02-25	セルゲイト，インコーポレイテッド	オリゴアルギニン部分を使用する上皮組織を横切るおよび上皮組織内への薬物送達の増強
JP2003508501A (ja)	1999-09-07	2003-03-04	コンジュケム，インコーポレーテッド	生物学的結合のための肺送達
OA12050A (en)	1999-09-30	2006-05-02	Neurogen Corp	Certain alkylene diamine-substituted heterocycles.
JP3492349B2 (ja) *	1999-10-19	2004-02-03	ニチユソリューション株式会社	繁殖用雌ブタの飼育方法及び繁殖用雌ブタ用飼料
ES2343124T3 (es)	1999-10-29	2010-07-23	Novartis Ag	Composiciones de polvo seco con dispersabilidad mejorada.
CA2325106A1 (en)	1999-12-06	2001-06-06	Stanley L. Gore	Compositions and methods for intranasal delivery of active agents to the brain
US6853310B2 (en) *	1999-12-29	2005-02-08	Ge Medical Systems Information Technologies, Inc.	Tri-mode medical telemetry antenna system
US7089934B2 (en) *	2000-02-28	2006-08-15	Vectura Limited	Delivery of oral drugs
WO2001076602A1 (en) *	2000-04-07	2001-10-18	Tap Pharmaceutical Products Inc.	Apomorphine derivatives and methods for their use
US6632047B2 (en)	2000-04-14	2003-10-14	Board Of Regents, The University Of Texas System	Heater element for use in an in situ thermal desorption soil remediation system
MY136453A (en) *	2000-04-27	2008-10-31	Philip Morris Usa Inc	"improved method and apparatus for generating an aerosol"
EP1292314A2 (en) *	2000-05-23	2003-03-19	The Trustees of Columbia University in the City of New York	Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
WO2001095903A1 (en)	2000-06-15	2001-12-20	Respiratorius Ab	5-ht3 receptor antagonists for treatment of disorders involving airway constriction
GB0015981D0 (en)	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
FR2812545B1 (fr)	2000-08-03	2003-03-28	Air Liquide Sante Int	Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
US6613308B2 (en)	2000-09-19	2003-09-02	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en)	2000-09-19	2003-02-04	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
WO2002056932A2 (en)	2000-10-27	2002-07-25	Emlin Biosciences	Thermal vaporizing device for drug delivery
EP1383376A4 (en) *	2001-03-19	2006-03-08	Praecis Pharm Inc	PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
US20030004142A1 (en) *	2001-04-18	2003-01-02	Prior Christopher P.	Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
ES2316571T3 (es)	2001-05-24	2009-04-16	Alexza Pharmaceuticals, Inc.	Administracion de alprazolam, estazolam, midazolam o triazolam a traves de una via inhalatoria.
EP1392260A2 (en)	2001-05-24	2004-03-03	Alexza Molecular Delivery Corporation	Delivery of benzodiazepines through an inhalation route
US6759029B2 (en)	2001-05-24	2004-07-06	Alexza Molecular Delivery Corporation	Delivery of rizatriptan and zolmitriptan through an inhalation route
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US20030131843A1 (en)	2001-11-21	2003-07-17	Lu Amy T.	Open-celled substrates for drug delivery
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7498019B2 (en)	2001-05-24	2009-03-03	Alexza Pharmaceuticals, Inc.	Delivery of compounds for the treatment of headache through an inhalation route
US20080038363A1 (en) *	2001-05-24	2008-02-14	Zaffaroni Alejandro C	Aerosol delivery system and uses thereof
US7645442B2 (en)	2001-05-24	2010-01-12	Alexza Pharmaceuticals, Inc.	Rapid-heating drug delivery article and method of use
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
EP1392262A1 (en)	2001-05-24	2004-03-03	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
US20030138508A1 (en)	2001-12-18	2003-07-24	Novack Gary D.	Method for administering an analgesic
US20030118512A1 (en)	2001-10-30	2003-06-26	Shen William W.	Volatilization of a drug from an inclusion complex
GB0126150D0 (en)	2001-10-31	2002-01-02	Gw Pharma Ltd	A device method and resistive element for vaporising a substance
WO2003041693A1 (en)	2001-11-09	2003-05-22	Alexza Molecular Delivery Corporation	Delivery of diazepam through an inhalation route
EP1446102A1 (en)	2001-11-21	2004-08-18	Alexza Molecular Delivery Corporation	Delivery of caffeine through an inhalation route
CN1327772C (zh)	2001-12-04	2007-07-25	诺和酶股份有限公司	杀死孢子的方法
US6701922B2 (en)	2001-12-20	2004-03-09	Chrysalis Technologies Incorporated	Mouthpiece entrainment airflow control for aerosol generators
US6772756B2 (en)	2002-02-09	2004-08-10	Advanced Inhalation Revolutions Inc.	Method and system for vaporization of a substance
EP1503744A1 (en)	2002-05-13	2005-02-09	Alexza Molecular Delivery Corporation	Delivery of drug amines through an inhalation route
US20060193788A1 (en)	2002-11-26	2006-08-31	Hale Ron L	Acute treatment of headache with phenothiazine antipsychotics
US7074806B2 (en) *	2002-06-06	2006-07-11	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7023427B2 (en)	2002-06-28	2006-04-04	Microsoft Corporation	Method and system for detecting multiple touches on a touch-sensitive screen
US7485143B2 (en) *	2002-11-15	2009-02-03	Abbott Cardiovascular Systems Inc.	Apparatuses and methods for heart valve repair
KR100459905B1 (ko) *	2002-11-21	2004-12-03	삼성전자주식회사	두 개의 잉크챔버 사이에 배치된 히터를 가진 일체형잉크젯 프린트헤드 및 그 제조방법
US7550133B2 (en)	2002-11-26	2009-06-23	Alexza Pharmaceuticals, Inc.	Respiratory drug condensation aerosols and methods of making and using them
US20040105818A1 (en)	2002-11-26	2004-06-03	Alexza Molecular Delivery Corporation	Diuretic aerosols and methods of making and using them
CA2507158A1 (en)	2002-11-26	2004-06-10	Alexza Molecular Delivery Corporation	Treatment of headache with antipsychotics delivered by inhalation
CA2507159A1 (en)	2002-11-26	2004-06-10	Alexza Molecular Delivery Corporation	Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
US7913688B2 (en)	2002-11-27	2011-03-29	Alexza Pharmaceuticals, Inc.	Inhalation device for producing a drug aerosol
JP2007516149A (ja)	2003-05-21	2007-06-21	アレックザファーマシューティカルズ，インコーポレイテッド	基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
ATE470468T1 (de)	2003-08-04	2010-06-15	Alexza Pharmaceuticals Inc	Substrate für eine medikamentenverabreichungsvorrichtung und verfahren zur bereitung
US20050037506A1 (en)	2003-08-04	2005-02-17	Alexza Molecular Delivery Corporation	Methods of determining film thicknesses for an aerosol delivery article
WO2005061033A1 (en)	2003-12-15	2005-07-07	Alexza Pharmaceuticals, Inc.	Treatment of breakthrough pain by drug aerosol inhalation
US20050131739A1 (en)	2003-12-16	2005-06-16	Alexza Molecular Delivery Corporation	Methods for monitoring severity of panic attacks and other rapidly evolving medical events in real time
US7402777B2 (en)	2004-05-20	2008-07-22	Alexza Pharmaceuticals, Inc.	Stable initiator compositions and igniters
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20060032496A1 (en)	2004-08-12	2006-02-16	Alexza Molecular Delivery Corporation	Inhalation actuated percussive ignition system
EP1781360A1 (en)	2004-08-12	2007-05-09	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
EP1809240A4 (en)	2004-10-12	2010-06-16	Alexza Pharmaceuticals Inc	ADMINISTRATION OF A DRUG-FREE DRUG WITHOUT DANGER TO THE CARDIOVASCULAR SYSTEM
TWI324496B (en)	2005-05-27	2010-05-01	Au Optronics Corp	Organic light-emitting diode and manufacturing method thereof
JP2009530390A (ja) *	2006-03-23	2009-08-27	アムゲンインコーポレイティッド	１−フェニルスルホニル−ジアザ複素環アミド化合物およびヒドロキシステロイドデヒドロゲナーゼ調節因子としてのその使用
US20080299048A1 (en)	2006-12-22	2008-12-04	Alexza Pharmaceuticals, Inc.	Mixed drug aerosol compositions
EP2121088B1 (en)	2007-03-09	2016-07-13	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
US20080306285A1 (en)	2007-04-27	2008-12-11	Alexza Pharmaceuticals, Inc.	Heat-Labile Prodrugs

2002
- 2002-05-13 EP EP02741994A patent/EP1392262A1/en not_active Withdrawn
- 2002-05-13 JP JP2003530268A patent/JP2005503425A/ja active Pending
- 2002-05-13 CA CA002446904A patent/CA2446904A1/en not_active Abandoned
- 2002-05-13 US US10/146,516 patent/US6737042B2/en not_active Expired - Fee Related
- 2002-05-15 AU AU2002314784A patent/AU2002314784A1/en not_active Abandoned
- 2002-05-15 US US10/150,268 patent/US6780399B2/en not_active Expired - Fee Related
- 2002-05-15 US US10/150,267 patent/US6797259B2/en not_active Expired - Fee Related
- 2002-05-16 US US10/151,596 patent/US6855310B2/en not_active Expired - Fee Related
- 2002-05-16 EP EP02729255A patent/EP1389095A1/en not_active Withdrawn
- 2002-05-16 US US10/151,626 patent/US6783753B2/en not_active Expired - Lifetime
- 2002-05-17 US US10/150,591 patent/US6780400B2/en not_active Expired - Lifetime
- 2002-05-17 ES ES08014271T patent/ES2341594T3/es not_active Expired - Lifetime
- 2002-05-17 US US10/150,857 patent/US6716415B2/en not_active Expired - Lifetime
- 2002-05-17 AT AT08014271T patent/ATE462420T1/de not_active IP Right Cessation
- 2002-05-17 EP EP02729235A patent/EP1389094B1/en not_active Expired - Lifetime
- 2002-05-17 EP EP02771848A patent/EP1392264B1/en not_active Expired - Lifetime
- 2002-05-17 ES ES02729235T patent/ES2312571T3/es not_active Expired - Lifetime
- 2002-05-17 NZ NZ529422A patent/NZ529422A/en unknown
- 2002-05-17 JP JP2002590949A patent/JP4578772B2/ja not_active Expired - Fee Related
- 2002-05-17 AT AT02729235T patent/ATE406878T1/de active
- 2002-05-17 DE DE60235851T patent/DE60235851D1/de not_active Expired - Lifetime
- 2002-05-17 AT AT02771848T patent/ATE401064T1/de not_active IP Right Cessation
- 2002-05-17 CA CA002446990A patent/CA2446990C/en not_active Expired - Fee Related
- 2002-05-17 EP EP08014271A patent/EP1987823B1/en not_active Expired - Lifetime
- 2002-05-20 DE DE60235852T patent/DE60235852D1/de not_active Expired - Lifetime
- 2002-05-20 JP JP2002590955A patent/JP4578773B2/ja not_active Expired - Lifetime
- 2002-05-20 DK DK02737053T patent/DK1389098T3/da active
- 2002-05-20 MX MXPA03010703A patent/MXPA03010703A/es active IP Right Grant
- 2002-05-20 US US10/152,640 patent/US6743415B2/en not_active Expired - Fee Related
- 2002-05-20 US US10/152,639 patent/US6716416B2/en not_active Expired - Lifetime
- 2002-05-20 AT AT02731896T patent/ATE404184T1/de not_active IP Right Cessation
- 2002-05-20 EP EP02731896A patent/EP1389097B1/en not_active Expired - Lifetime
- 2002-05-20 ES ES08014272T patent/ES2341392T3/es not_active Expired - Lifetime
- 2002-05-20 AT AT02737053T patent/ATE404173T1/de active
- 2002-05-20 US US10/152,652 patent/US6740307B2/en not_active Expired - Fee Related
- 2002-05-20 WO PCT/US2002/016118 patent/WO2002094236A1/en not_active Ceased
- 2002-05-20 US US10/153,139 patent/US6814954B2/en not_active Expired - Lifetime
- 2002-05-20 EP EP02737053A patent/EP1389098B1/en not_active Expired - Lifetime
- 2002-05-20 CA CA002446917A patent/CA2446917C/en not_active Expired - Lifetime
- 2002-05-20 DE DE60228232T patent/DE60228232D1/de not_active Expired - Lifetime
- 2002-05-20 PT PT02737053T patent/PT1389098E/pt unknown
- 2002-05-20 AU AU2002310015A patent/AU2002310015B2/en not_active Expired
- 2002-05-20 AT AT08014272T patent/ATE462421T1/de not_active IP Right Cessation
- 2002-05-20 NZ NZ529419A patent/NZ529419A/en unknown
- 2002-05-20 ES ES02737053T patent/ES2311607T3/es not_active Expired - Lifetime
- 2002-05-20 EP EP08014272A patent/EP1990046B1/en not_active Expired - Lifetime
- 2002-05-20 EP EP02737054A patent/EP1389099A1/en not_active Withdrawn
- 2002-05-20 PL PL02363996A patent/PL363996A1/xx unknown
- 2002-05-21 NZ NZ529420A patent/NZ529420A/en unknown
- 2002-05-21 EP EP02731894A patent/EP1389096B9/en not_active Expired - Lifetime
- 2002-05-21 ES ES02731894T patent/ES2324023T3/es not_active Expired - Lifetime
- 2002-05-21 EP EP02731930A patent/EP1392257B1/en not_active Expired - Lifetime
- 2002-05-21 US US10/153,839 patent/US6776978B2/en not_active Expired - Lifetime
- 2002-05-21 JP JP2002590964A patent/JP2004535403A/ja active Pending
- 2002-05-21 US US10/153,311 patent/US6884408B2/en not_active Expired - Fee Related
- 2002-05-21 PT PT02731894T patent/PT1389096E/pt unknown
- 2002-05-21 US US10/153,831 patent/US6740308B2/en not_active Expired - Lifetime
- 2002-05-21 CA CA002446916A patent/CA2446916C/en not_active Expired - Fee Related
- 2002-05-21 CA CA002447521A patent/CA2447521C/en not_active Expired - Fee Related
- 2002-05-21 AT AT02731930T patent/ATE401063T1/de not_active IP Right Cessation
- 2002-05-21 AU AU2002303833A patent/AU2002303833B2/en not_active Ceased
- 2002-05-21 NZ NZ529421A patent/NZ529421A/en unknown
- 2002-05-21 AT AT02731894T patent/ATE425746T1/de active
- 2002-05-22 US US10/155,705 patent/US6805854B2/en not_active Expired - Fee Related
- 2002-05-22 JP JP2002590938A patent/JP2004531556A/ja active Pending
- 2002-05-22 AT AT02737132T patent/ATE365548T1/de not_active IP Right Cessation
- 2002-05-22 NZ NZ529418A patent/NZ529418A/en unknown
- 2002-05-22 PL PL02363997A patent/PL363997A1/xx not_active Application Discontinuation
- 2002-05-22 DE DE60220909T patent/DE60220909T2/de not_active Expired - Lifetime
- 2002-05-22 EP EP02737132A patent/EP1392259B1/en not_active Expired - Lifetime
- 2002-05-22 CA CA002447166A patent/CA2447166C/en not_active Expired - Fee Related
- 2002-05-22 US US10/155,703 patent/US6803031B2/en not_active Expired - Fee Related
- 2002-05-23 AT AT02739410T patent/ATE418971T1/de not_active IP Right Cessation
- 2002-05-23 AT AT02737120T patent/ATE418330T1/de not_active IP Right Cessation
- 2002-05-23 EP EP02737120A patent/EP1390021B1/en not_active Expired - Lifetime
- 2002-05-23 US US10/154,765 patent/US6814955B2/en not_active Expired - Fee Related
- 2002-05-23 MX MXPA03010702A patent/MXPA03010702A/es active IP Right Grant
- 2002-05-23 CA CA2447099A patent/CA2447099C/en not_active Expired - Fee Related
- 2002-05-23 EP EP02739410A patent/EP1392261B1/en not_active Expired - Lifetime
- 2002-05-23 US US10/154,594 patent/US6740309B2/en not_active Expired - Fee Related
- 2002-05-23 JP JP2002590960A patent/JP2004532860A/ja active Pending
- 2002-05-23 US US10/155,097 patent/US6716417B2/en not_active Expired - Fee Related
- 2002-05-23 PL PL02364002A patent/PL364002A1/xx unknown
- 2002-05-23 NZ NZ529416A patent/NZ529416A/en unknown
2003
- 2003-12-12 US US10/734,902 patent/US7029658B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,199 patent/US7070761B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,198 patent/US7008615B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,497 patent/US7070762B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,496 patent/US7005121B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,783 patent/US7078019B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,539 patent/US7078018B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/750,303 patent/US7078020B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/749,535 patent/US7115250B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,536 patent/US7094392B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,537 patent/US7078017B2/en not_active Expired - Lifetime
2004
- 2004-01-27 US US10/766,634 patent/US7070763B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,279 patent/US7087217B2/en not_active Expired - Fee Related
- 2004-01-27 US US10/766,566 patent/US7060254B2/en not_active Expired - Fee Related
- 2004-01-27 US US10/766,149 patent/US7087216B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,574 patent/US7045118B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,647 patent/US7070764B2/en not_active Expired - Fee Related
- 2004-01-28 US US10/767,115 patent/US7052679B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,205 patent/US7070765B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,220 patent/US7063830B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/769,197 patent/US7063831B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/768,293 patent/US7067114B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/768,281 patent/US7169378B2/en not_active Expired - Lifetime
- 2004-01-30 US US10/769,046 patent/US7070766B2/en not_active Expired - Fee Related
- 2004-01-30 US US10/769,051 patent/US7033575B2/en not_active Expired - Fee Related
- 2004-02-09 US US10/775,583 patent/US7018620B2/en not_active Expired - Fee Related
- 2004-02-09 US US10/775,586 patent/US7048909B2/en not_active Expired - Fee Related
- 2004-03-03 US US10/791,915 patent/US7005122B2/en not_active Expired - Fee Related
- 2004-03-03 US US10/792,239 patent/US7014840B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/814,690 patent/US7014841B2/en not_active Expired - Lifetime
- 2004-03-31 US US10/813,722 patent/US7063832B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/814,998 patent/US7108847B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/813,721 patent/US7022312B2/en not_active Expired - Lifetime
- 2004-04-01 US US10/816,567 patent/US7052680B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,492 patent/US7008616B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,407 patent/US7011820B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/815,527 patent/US6994843B2/en not_active Expired - Fee Related
2006
- 2006-03-07 US US11/370,628 patent/US7442368B2/en not_active Expired - Fee Related
- 2006-04-04 US US11/398,383 patent/US7449172B2/en not_active Expired - Lifetime
- 2006-05-24 US US11/439,475 patent/US7465435B2/en not_active Expired - Fee Related
- 2006-05-30 US US11/442,917 patent/US7465436B2/en not_active Expired - Fee Related
- 2006-06-13 US US11/451,853 patent/US7485285B2/en not_active Expired - Fee Related
- 2006-06-16 US US11/454,573 patent/US7465437B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,361 patent/US7524484B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,509 patent/US7507398B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,892 patent/US7449174B2/en not_active Expired - Fee Related
- 2006-07-05 US US11/481,279 patent/US7449175B2/en not_active Expired - Fee Related
- 2006-07-18 US US11/488,943 patent/US20060257329A1/en not_active Abandoned
- 2006-07-18 US US11/488,932 patent/US7601337B2/en not_active Expired - Lifetime
- 2006-08-07 US US11/501,246 patent/US7510702B2/en not_active Expired - Fee Related
- 2006-08-07 US US11/500,735 patent/US7445768B2/en not_active Expired - Fee Related
- 2006-08-22 US US11/507,986 patent/US7491047B2/en not_active Expired - Fee Related
- 2006-09-19 US US11/523,685 patent/US7507397B2/en not_active Expired - Fee Related
2007
- 2007-01-09 US US11/621,397 patent/US7468179B2/en not_active Expired - Fee Related
2008
- 2008-03-27 US US12/057,330 patent/US7988952B2/en not_active Expired - Fee Related
2009
- 2009-03-27 US US12/413,339 patent/US8173107B2/en not_active Expired - Fee Related
2010
- 2010-07-23 JP JP2010165688A patent/JP5629151B2/ja not_active Expired - Lifetime
2013
- 2013-08-19 FR FR13C0051C patent/FR13C0051I1/fr active Active
- 2013-08-19 BE BE2013C054C patent/BE2013C054I2/nl unknown

Also Published As

Publication number	Publication date
EP1390021A1 (en)	2004-02-25
BE2013C054I2 (ja)	2021-07-19
US7070766B2 (en)	2006-07-04
US6797259B2 (en)	2004-09-28
CA2446916C (en)	2009-12-22
NZ529419A (en)	2006-11-30
US7524484B2 (en)	2009-04-28
DE60235851D1 (de)	2010-05-12
US7045118B2 (en)	2006-05-16
US20040184997A1 (en)	2004-09-23
EP1389098B1 (en)	2008-08-13
CA2446917C (en)	2009-12-22
US20040191182A1 (en)	2004-09-30
US20040202617A1 (en)	2004-10-14
US20060233719A1 (en)	2006-10-19
US7052680B2 (en)	2006-05-30
CA2447166A1 (en)	2002-11-28
CA2447099C (en)	2010-01-26
US20060216244A1 (en)	2006-09-28
US20070014737A1 (en)	2007-01-18
ES2341392T3 (es)	2010-06-18
ES2341594T3 (es)	2010-06-22
CA2446916A1 (en)	2002-11-28
US20040228807A1 (en)	2004-11-18
US20040185007A1 (en)	2004-09-23
US20030017119A1 (en)	2003-01-23
US20030017115A1 (en)	2003-01-23
EP1987823B1 (en)	2010-03-31
US20040185002A1 (en)	2004-09-23
US7169378B2 (en)	2007-01-30
US6855310B2 (en)	2005-02-15
US7005121B2 (en)	2006-02-28
US7510702B2 (en)	2009-03-31
US7445768B2 (en)	2008-11-04
US20060286043A1 (en)	2006-12-21
US20040185001A1 (en)	2004-09-23
US20040191181A1 (en)	2004-09-30
US20030000518A1 (en)	2003-01-02
US20060269487A1 (en)	2006-11-30
US6716415B2 (en)	2004-04-06
US20030206869A1 (en)	2003-11-06
US7491047B2 (en)	2009-02-17
US7070761B2 (en)	2006-07-04
US20030012737A1 (en)	2003-01-16
US7465435B2 (en)	2008-12-16
NZ529422A (en)	2006-11-30
US7008615B2 (en)	2006-03-07
ATE404184T1 (de)	2008-08-15
US7070765B2 (en)	2006-07-04
US7468179B2 (en)	2008-12-23
US7507397B2 (en)	2009-03-24
PL363996A1 (en)	2004-11-29
US20030017114A1 (en)	2003-01-23
US20030021753A1 (en)	2003-01-30
ATE406878T1 (de)	2008-09-15
JP5629151B2 (ja)	2014-11-19
NZ529418A (en)	2006-11-30
US20030012740A1 (en)	2003-01-16
US7008616B2 (en)	2006-03-07
US20030017117A1 (en)	2003-01-23
US7067114B2 (en)	2006-06-27
DK1389098T3 (da)	2008-11-10
JP2010270138A (ja)	2010-12-02
DE60235852D1 (de)	2010-05-12
US7063830B2 (en)	2006-06-20
US20040184996A1 (en)	2004-09-23
US20050089479A1 (en)	2005-04-28
US20060216243A1 (en)	2006-09-28
US20060153779A1 (en)	2006-07-13
US20060251588A1 (en)	2006-11-09
US20040191185A1 (en)	2004-09-30
US20030015190A1 (en)	2003-01-23
US20040170573A1 (en)	2004-09-02
DE60220909T2 (de)	2008-02-28
US7442368B2 (en)	2008-10-28
US6803031B2 (en)	2004-10-12
US20040185004A1 (en)	2004-09-23
US6780400B2 (en)	2004-08-24
US6740308B2 (en)	2004-05-25
US7465437B2 (en)	2008-12-16
AU2002303833B2 (en)	2007-11-29
US7063831B2 (en)	2006-06-20
US7029658B2 (en)	2006-04-18
ATE425746T1 (de)	2009-04-15
EP1392261B1 (en)	2008-12-31
CA2446990A1 (en)	2002-11-28
US20040191179A1 (en)	2004-09-30
US20040156791A1 (en)	2004-08-12
US7022312B2 (en)	2006-04-04
US20060251587A1 (en)	2006-11-09
ATE401063T1 (de)	2008-08-15
US7449172B2 (en)	2008-11-11
US7018620B2 (en)	2006-03-28
US20040184999A1 (en)	2004-09-23
PT1389096E (pt)	2009-06-12
US20040170569A1 (en)	2004-09-02
CA2447166C (en)	2009-12-22
CA2447521A1 (en)	2002-11-28
ATE462420T1 (de)	2010-04-15
EP1392257A1 (en)	2004-03-03
US20090246147A1 (en)	2009-10-01
US20060286042A1 (en)	2006-12-21
US20040185006A1 (en)	2004-09-23
US20030015189A1 (en)	2003-01-23
CA2446917A1 (en)	2002-11-28
US20040191183A1 (en)	2004-09-30
US6780399B2 (en)	2004-08-24
WO2002094236A1 (en)	2002-11-28
US7108847B2 (en)	2006-09-19
NZ529416A (en)	2006-11-30
NZ529421A (en)	2006-11-30
US20060280692A1 (en)	2006-12-14
US20040156788A1 (en)	2004-08-12
US20040184998A1 (en)	2004-09-23
DE60228232D1 (de)	2008-09-25
JP2004532860A (ja)	2004-10-28
US20040127481A1 (en)	2004-07-01
US20040186130A1 (en)	2004-09-23
CA2446904A1 (en)	2003-04-03
US20040191184A1 (en)	2004-09-30
US6743415B2 (en)	2004-06-01
US20030021755A1 (en)	2003-01-30
US20080175796A1 (en)	2008-07-24
US7033575B2 (en)	2006-04-25
US7078018B2 (en)	2006-07-18
US6884408B2 (en)	2005-04-26
EP1990046A1 (en)	2008-11-12
EP1389096B9 (en)	2009-08-26
EP1392264A1 (en)	2004-03-03
US20060246012A1 (en)	2006-11-02
ATE418971T1 (de)	2009-01-15
EP1392262A1 (en)	2004-03-03
US7078019B2 (en)	2006-07-18
US20040185008A1 (en)	2004-09-23
US20060239936A1 (en)	2006-10-26
US7063832B2 (en)	2006-06-20
US7070763B2 (en)	2006-07-04
ATE418330T1 (de)	2009-01-15
US20040126326A1 (en)	2004-07-01
US7087217B2 (en)	2006-08-08
US20050075273A1 (en)	2005-04-07
EP1389094A1 (en)	2004-02-18
US7078017B2 (en)	2006-07-18
US20030007933A1 (en)	2003-01-09
US7011820B2 (en)	2006-03-14
NZ529420A (en)	2006-11-30
US7070764B2 (en)	2006-07-04
US20060257329A1 (en)	2006-11-16
US6814955B2 (en)	2004-11-09
JP2004531556A (ja)	2004-10-14
EP1389096A1 (en)	2004-02-18
MXPA03010702A (es)	2004-03-02
US20040156790A1 (en)	2004-08-12
WO2002094236A9 (en)	2006-11-16
US20030017118A1 (en)	2003-01-23
EP1392259A2 (en)	2004-03-03
US6740307B2 (en)	2004-05-25
US7988952B2 (en)	2011-08-02
PL364002A1 (pl)	2004-11-29
US20060177382A1 (en)	2006-08-10
EP1389095A1 (en)	2004-02-18
ATE365548T1 (de)	2007-07-15
US6994843B2 (en)	2006-02-07
US20030017120A1 (en)	2003-01-23
EP1392264B1 (en)	2008-07-16
US7005122B2 (en)	2006-02-28
AU2002314784A1 (en)	2002-12-03
JP4578772B2 (ja)	2010-11-10
CA2447521C (en)	2009-12-29
EP1389097A1 (en)	2004-02-18
US20040167228A1 (en)	2004-08-26
EP1389098A1 (en)	2004-02-18
US7070762B2 (en)	2006-07-04
US20030005924A1 (en)	2003-01-09
ES2324023T3 (es)	2009-07-29
US20040161385A1 (en)	2004-08-19
EP1389097B1 (en)	2008-08-13
US7014841B2 (en)	2006-03-21
US8173107B2 (en)	2012-05-08
ATE401064T1 (de)	2008-08-15
US7094392B2 (en)	2006-08-22
MXPA03010703A (es)	2004-07-01
US7060254B2 (en)	2006-06-13
US6783753B2 (en)	2004-08-31
US6716417B2 (en)	2004-04-06
US7485285B2 (en)	2009-02-03
EP1392259B1 (en)	2007-06-27
EP1390021B1 (en)	2008-12-24
US20040126329A1 (en)	2004-07-01
US7601337B2 (en)	2009-10-13
PL363997A1 (pl)	2004-11-29
US20030021754A1 (en)	2003-01-30
JP2004535403A (ja)	2004-11-25
US20070178052A1 (en)	2007-08-02
US7078020B2 (en)	2006-07-18
US20040156789A1 (en)	2004-08-12
US7449174B2 (en)	2008-11-11
JP4578773B2 (ja)	2010-11-10
JP2005503425A (ja)	2005-02-03
US6737042B2 (en)	2004-05-18
US20040126327A1 (en)	2004-07-01
US20030007934A1 (en)	2003-01-09
US6740309B2 (en)	2004-05-25
US20040185000A1 (en)	2004-09-23
US20040126328A1 (en)	2004-07-01
US6716416B2 (en)	2004-04-06
US7449175B2 (en)	2008-11-11
US7465436B2 (en)	2008-12-16
ES2311607T3 (es)	2009-02-16
US20040185005A1 (en)	2004-09-23
JP2004532859A (ja)	2004-10-28
US7087216B2 (en)	2006-08-08
US7507398B2 (en)	2009-03-24
CA2447099A1 (en)	2002-11-28
US20060246011A1 (en)	2006-11-02
US6814954B2 (en)	2004-11-09
US7115250B2 (en)	2006-10-03
EP1389099A1 (en)	2004-02-18
US20030017116A1 (en)	2003-01-23
US20040191180A1 (en)	2004-09-30
US7048909B2 (en)	2006-05-23
PT1389098E (pt)	2008-11-14
ATE404173T1 (de)	2008-08-15
US6805854B2 (en)	2004-10-19
US7014840B2 (en)	2006-03-21
EP1389094B1 (en)	2008-09-03
EP1392257B1 (en)	2008-07-16
EP1990046B1 (en)	2010-03-31
DE60220909D1 (de)	2007-08-09
JP2004536805A (ja)	2004-12-09
US7052679B2 (en)	2006-05-30
EP1987823A1 (en)	2008-11-05
EP1389096B1 (en)	2009-03-18
ATE462421T1 (de)	2010-04-15
AU2002310015B2 (en)	2008-09-04
ES2312571T3 (es)	2009-03-01
US6776978B2 (en)	2004-08-17
CA2446990C (en)	2009-12-22
EP1392261A2 (en)	2004-03-03

Publication	Publication Date	Title
FR13C0051I1 (fr)	2013-09-27	Administration d'antipsychotiques par inhalation
WO2002094218A3 (en)	2003-03-06	Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
WO2002094244A3 (en)	2003-01-16	Delivery of benzodiazepines through an inhalation route
HUS1900056I1 (hu)	2020-02-28	Légzési rendellenességek kezelésére alkalmas, glikopirrolát tartalmú száraz porkészítményt tartalmazó inhaláló készülék és alkalmazása
NZ507151A (en)	2002-11-26	Pulmonary and nasal delivery of raloxifene
WO2002098390A3 (en)	2003-02-20	Delivery of aerosols containing small particles through an inhalation route
ATE271383T1 (de)	2004-08-15	Pulverformulierung zur inhalation
BR0309117A (pt)	2005-02-01	Kit de inalação compreendendo pó inalável de tiotropium
GB0127989D0 (en)	2002-01-16	Medicament dispensing system
ATE545442T1 (de)	2012-03-15	Medizinische vorrichtung zur inhalation von aerosolisiertem arzneimittel mit heliox
MXPA02011311A (es)	2003-04-25	Composicion novedosa.
ATE333500T1 (de)	2006-08-15	Virus des porzinen reproduktiven und respiratorischen syndroms und dessen verwendung
IL101056A (en)	1997-03-18	Composition for nasal treatment
EP1224003B8 (en)	2006-05-17	Combination mouthpiece for inhalation therapy devices used by oxygen dependent patients
WO2002094219A3 (en)	2003-03-06	Delivery of erectile dysfunction drugs through an inhalation route
WO2002094216A3 (en)	2003-10-16	Delivery of stimulants through an inhalation route
MXPA04007294A (es)	2004-10-29	Composicion para inhalacion.
MXPA04002401A (es)	2004-05-31	Nuevos medicamentos para inhalacion.
TWI256388B (en)	2006-06-11	Pharmaceutical combination
WO2003094694A3 (en)	2004-03-18	Hand held device for inhalation therapy and method of use thereof